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Kombucha is a SCOBY-fermented tea beverage known for its taste, sensorial qualities,
and high endogenous microbial load. In recent years, kombucha has become a popular functional
food with a compound annual growth rate of 25% from 2015 to 2020 in American kombucha
sales alone, and sales are predicted to keep increasing significantly over the next decade.
However, kombucha is lacking in scientific research, and there is still much to be explored
regarding its safety and native probiotic content. This research looked into the various routes of
contamination of several kombucha systems as well as the feasibility of the producing a
kombucha beverage with health-promoting characteristics derived from the inclusion of lactic
probiotics.
Although bacterial spore contamination and survival in the kombucha SCOBY have been
documented, it is unknown whether spores can survive in the liquid, or whether they can be
transmitted to daughter SCOBYs. The foodborne pathogen and spore-former Bacillus cereus was
inoculated into the SCOBY, unfermented liquid, and fermented liquid of three different

kombucha systems. Data suggest that neither the route of contamination nor the kombucha
system influenced the transmission or survival of B. cereus spores. The spread of the spores
between culture and liquid across generation was shown to be sporadic but possible, so hygienic
handling of kombucha cultures and raw materials throughout the entire production process is
crucial to prevent uptake of pathogenic organisms. There was no survival of B. cereus spores
after short-term storage or secondary fermentation, indicating that implementation of a holding
step may mitigate potential food safety threats.
Kombucha is perceived to contain probiotics, but not all live cultures comprise
probiotics. Some commercial kombucha products have validated probiotic strains added to them
post-fermentation, but this can be costly. If probiotics, such as lactic acid bacteria, are inoculated
into sweet tea prior to fermentation, they may be able to acidify the tea, replacing the need for
utilizing previous kombucha or acetic acid, or survive and/or produce beneficial metabolites
during fermentation in great enough amounts to convey a health benefit upon consumption. The
survivability of six probiotic Lactobacillus sp. in acidified, sweetened tea at 25ºC during
kombucha fermentation was established, and the medium (tea) and temperature (25ºC) were both
revealed to affect the growth rates of the bacteria. Differences in pH indicated that the probiotics
were unable to acidify the tea pre-fermentation. Although survival during fermentation was
possible for four out of the six probiotics, it was concluded that probiotic Lactobacillus sp. are
not well suited for a probiotic kombucha beverages, but out of the tested probiotics,
Lactobacillus brevis and Lactobacillus fermentum were the most promising candidates.
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CHAPTER 1
LITERATURE REVIEW
1.1. Introduction
Kombucha is a fermented tea beverage with a mildly sweet, tangy, acidic taste known for
its functional properties and claimed health benefits. Also referred to as mushroom tea, haipao,
tea kvass, or teakwass, this beverage is made by using green, black, or oolong tea and a
symbiotic colony of bacteria and yeasts (or SCOBY) fermented under aerobic conditions (Chen
& Liu, 2000; Liu et al., 1996; Kumar & Joshi, 2016; Kim & Adhikari, 2020). Originating in
China in 220 BCE, kombucha can now be found all over the globe from the United States to
Australia to Europe to Russia and back to Asia (Chakravorty et al., 2019). While it was
originally only made in the home, kombucha is now commercially produced and can be found on
grocery store shelves in the refrigerated “health beverage” section. Popular brands today include
Kevita (PepsiCo), Health-Ade (Coca-Cola, as investor), Brew Dr. Kombucha, GT’s Synergy,
Kombrewcha, Clearly Kombucha (Molson Coors), and more (PepsiCo, 2016; Molson Coors
Beer & Beyond, 2018; Food Dive, 2019). The purported health benefits of kombucha include,
but are not limited to, enhancing gut health, probiotic presence, antioxidant capabilities,
antimicrobial characteristics, prevention of cardiovascular, kidney, and liver disease, and
lowering high cholesterol and blood pressure have been reviewed in literature (Vīna et al., 2013).
However, many of these health claims have little scientific evidence to support them. There are
many models evaluating these health claims in animal trials, but there are few to no human trials
providing evidence for these claims (Jayabalan et al., 2014). As a result, it cannot be determined
whether kombucha’s constituents will have the same effects in the human body as those that
have been demonstrated in animal models.
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1.1.1. History and Rise in Popularity
The exact origins and commencement of kombucha production are unknown, but experts
estimate the beverage originated in northeast China, then Manchuria, during the Tsin dynasty in
220 BCE, although the process of fermentation significantly predates this time (Chakravorty et
al., 2019). Kombucha was said to have been popular for its detoxifying and energizing
properties. From there, the fermented beverage made its way to Japan around 414 CE when the
physician Kombu used it to cure Emperor Inkyo’s digestive problems. It is believed “kombucha”
gets its name from the physician Kombu (Chakravorty et al., 2019; Bauer, n.d.). From Japan,
kombucha expanded via trade routes to Russia, Eastern Europe, and eventually Germany. After
WWII, when supplies were finally replenished, the beverage became popular throughout Europe
and North Africa eventually making its way to the rest of the Western world (Chakravorty et al.,
2019; Bauer, n.d.).
Kombucha first became popular in the United States during the HIV/AIDS epidemic in
the late 1980s and early 1990s in hopes that its health benefits would slow the progression of the
disease by increasing T-cell counts and supporting compromised immune systems (Petruzzello,
n.d.). It was mostly made at home until the 1990s when GT Dave started the first U.S.
commercial brand, GT’s kombucha, in 1995 (Kombucha Brewers International, n.d.; Troitino,
2017). He started the company partially due to his belief that the beverage had cured his
mother’s cancer (Troitino, 2017). Dave wanted to educate people about the product and share its
potential health benefits with others. However, in 1995 the Centers for Disease Control and
Prevention (CDC) released a report on two cases of severe metabolic acidosis in Iowa that were
suspected to have been caused by excessive kombucha consumption, although a direct cause for
the acidosis was never established (CDC, 1995; Petruzzello, n.d.). Consequently, the beverage’s
2

popularity dwindled until the beginning of the 21st century when it resurged as a health product
because of public motivation towards a healthier lifestyle and greater awareness of probiotics
and the health benefits of fermented foods (Petruzzello, n.d.). It was at this time that growing
curiosity surrounding kombucha and growing popularity for health foods started expanding the
beverage’s recognition. Kombucha has since become the fastest-growing product in the
functional beverage sector (Bauer, n.d.; Kombucha Brewers International, n.d.).
The rise in kombucha’s popularity goes hand-in-hand with the rise of the functional foods
movement. The functional foods movement is a push driven by the public to move towards a
healthier lifestyle. This primarily consisted of a shift towards healthier eating habits or
consuming foods that were known to be good for health or have health benefits. What
distinguishes a product as a “functional food” can vary from person to person, but it is generally
defined as a food that goes beyond basic nutrition and contains ingredients that beneficially
influence specific body functions (Tur & Bibiloni, 2016; Corbo et al., 2014; Hasler, 2002). In the
United States, the movement started around the late 1980s/early 1990s when the demand for
more healthful foods and beverages began to rise. As life expectancy, health care costs, and the
desire for higher quality of life increased, people became more concerned for their health and
what they were consuming (Tur & Bibiloni, 2016). Heart disease, weight and obesity, cancer,
diabetes, nutrition, and exercise remain some of the top health concerns among Americans
(Kapsak et al., 2011). As a result, the functional foods and beverages global market grew from
$33 billion in 2000 to $176.7 billion in 2013, accounting for 5% of the food market overall
(Tripathi & Giri, 2014).
Functional foods are more of a concept than a well-defined group of foods, lacking
universal standards or regulatory definition (Tur & Bibiloni, 2016; Corbo et al., 2014; Hasler,
3

2002; Siró et al., 2008). In the United States, functional foods are loosely defined as “foods and
food components that provide a health benefit beyond basic nutrition” (Bacillus cereus—BfR,
n.d.). There is no separate category or set of regulations for functional foods in United States,
and thus they fall under the regulations for conventional foods (Corbo et al., 2014). Functional
foods can be a natural food (found “as-is” in nature) or a food containing one or more ingredients
that positively affect the health and well-being of the consumer. These ingredients can be added
to or removed from food, naturally enhanced through special conditions, or modified to provide
health benefits (Tur & Bibiloni, 2016). Examples include fortified milk or juice, yogurt,
cholesterol-lowering spreads, eggs enhanced with omega-3 fatty acids, kefir, kombucha, and
more (Siró et al., 2008; Jędrusek-Golińska et al., 2020; Bigliardi & Galati, 2013). The earliest
functional foods were those fortified with vitamins and/or minerals such as vitamin C, vitamin D,
calcium, iron, and folic acid (Siró et al., 2008). This quickly shifted to foods being fortified with
more complex micronutrients such as omega-3 fatty acids, phytosterol, and soluble fiber with the
intention to promote good health and disease prevention (Siró et al., 2008). Today, functional
foods are being developed and produced to offer multiple health benefits within a single product
(Siró et al., 2008). However, functional foods are not a panacea; they do not cure or prevent
illnesses alone and are not essential to the diet (Tur & Bibiloni, 2016).
Kombucha is one of the most popular and recognized beverages to be associated with
functional foods because of its claimed health benefits. Although the commercial kombucha
market is very young, its size and product variety are growing very rapidly (Urala &
Lähteenmäki, 2003; Back, 2018). Between 2010 and 2014, kombucha sales in the United States
almost quadrupled, going from a little more than $100 million to almost $400 million (Troitino,
2017). By February 2019, yearly sales of kombucha were at $728.8 million, and kombucha
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consumption increased 22% from the previous year (Bauer, n.d.). From 2015 to 2020, domestic
kombucha sales had a compound annual growth rate (CAGR) of 25%, and sales are predicted to
increase significantly over the next decade (Troitino, 2017).

1.2. Claimed Health Benefits
There is a wide variety of benefits that kombucha is said to possess. These claimed benefits
span from improving gut health due to probiotic presence to antioxidant and radical scavenger
capabilities to antimicrobial properties to hepatoprotection to the prevention of numerous health
issues such as cardiovascular diseases, cancer, high cholesterol and blood pressure, etc.
(Chakravorty et al., 2019; Chu & Chen, 2006; Velićanski et al., 2007; Wang et al., 2014;
Deghrigue et al., 2013; Jayabalan, Baskaran, et al., 2010; Srihari & Satyanarayana, 2012;
Sreeramulu et al., 2001; Watawana et al., 2018; Yang et al., 2009). These claims stem from
either the probiotic effect, where consumed viable microorganisms interact with the host, or
indirectly through the biogenic effect, caused by the ingestion of microbial metabolites produced
during fermentation (Tripathi & Giri, 2014). The majority of kombucha’s health benefits can be
largely attributed to its level of catechin, derived from its tea base; it protects against the
development of diseases in addition to being a powerful antioxidant (Leal et al., 2018; Cardoso
et al., 2020).
While many studies have been conducted on these potential health benefits, most, if not
all, of them lack the scientific evidence proving or guaranteeing them in humans because the
studies use animal models instead of human models (Chakravorty et al., 2019). The animal
models are helpful for understanding the mechanisms of the bioactive contents found in
kombucha in vivo, however, they may act differently in mice or rats than they do in humans
5

(Gedela et al., 2016; SungHee et al., 2009; Kapp & Sumner, 2019). As a result, we cannot expect
the same effects happening in these animal models once having consumed kombucha to be
transferred over to humans. The evidence is promising, but further research in a human system is
needed to validate these health benefits in humans. To date, there have been no kombucha
consumption studies using human models to confirm these health benefits.

1.2.1. Antioxidant Activity
Kombucha exhibits good antioxidant and free radical scavenging activity, which increases
over [a normal period of] fermentation (Chu & Chen, 2006; Srihari & Satyanarayana, 2012;
Mizuta et al., 2020). The antioxidant activity is dependent on the type of tea used and the
SCOBY culture composition; this determines the amount and type of antioxidants and
metabolites produced (Chu & Chen, 2006; Jakubczyk et al., 2020). Other types of tea, such as
green tea, red tea, and purple basil tea, have shown to be equal to or more rich in antioxidant than
traditional black tea (Jakubczyk et al., 2020; Yıkmış & Tuğgüm, 2019). Although unfermented
tea does exhibit some antioxidant activity, kombucha has proven to have a higher antioxidant
activity than unfermented tea in many studies (Velićanski et al., 2007; Velićanski et al., 2014;
Bhattacharya et al., 2013). This is mostly like due to the SCOBY metabolites produced during
fermentation.
Phenolic compounds and SCOBY metabolites are responsible for kombucha’s antioxidant
activity and free radical scavenging properties (Velićanski et al., 2014). These phenolic
compounds consist of polyphenols, which include catechins, theaflavins, thearubigins, and
flavonoids (Jayabalan et al., 2014; Jakubczyk et al., 2020; Jayabalan, Baskaran, et al., 2010;
Srihari & Satyanarayana, 2012). Phenolic compounds are high-level antioxidants with a strong
6

ability to scavenge free-radical and active oxygen species such as singlet oxygen, superoxide free
radicals, and hydroxyl radicals (Velićanski et al., 2014). Conversely, the SCOBY metabolites
contributing to kombucha’s antioxidant capabilities mostly consist of vitamins and organic acids
such as B and C vitamins, ascorbic acid, malic acid, tartaric acid, and acetic acid (Jayabalan et
al., 2014; Srihari & Satyanarayana, 2012). Vitamin C especially is known to be an antioxidant
with important immunological function (Riol et al., 2018).
Kombucha’s antioxidant activity may also contribute to preventing the development and
progression of chronic diseases such as cardiovascular disease, cancer, diabetes, and
neurodegenerative diseases (Baschali et al., 2017). Folic acid and other B vitamins present in
kombucha help promote proper central nervous system function at all ages as well as help
prevent various central nervous system disorders (Baschali et al., 2017).

1.2.2. Antimicrobial Activity
Kombucha’s antimicrobial activity is largely attributed to its low pH, presence of various
organic acids (acetic acid, succinic acid, gluconic acid, etc.), large proteins, polyphenols
(catechin and isorhamnetin), and SCOBY metabolites produced during fermentation (Jayabalan
et al., 2014; Ivanišová et al., 2020; Leal et al., 2018; Greenwalt et al., 2000; Greenwalt et al.,
1998; Deghrigue et al., 2013; Bhattacharya et al., 2016; Sreeramulu et al., 2001; Talawat et al.,
2006; Battikh et al., 2013). The contribution of tea itself to the antimicrobial activity of
Kombucha proved to be insignificant (Greenwalt et al., 1998). Phenolic compounds and
flavonoids are known to be effective antimicrobial agents, which includes the polyphenols
catechin and isorhamnetin. Catechin, which is also found in unfermented tea, and isorhamnetin,
which is not, were determined to be great antibacterial compounds because of their ability to
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target bacterial virulence factors and permeate bacterial cell membranes by generating oxidative
stress (Bhattacharya et al., 2020; Bhattacharya et al., 2016; Bhattacharya et al., 2018). Thus,
bacterial pathogenicity is mitigated, and any contaminated kombucha is less likely to cause
illness. Četojević-Simin et al. (2012)’s study determined acetic acid was one of the main
antimicrobial agents of kombucha (Četojević-Simin et al., 2012). However, other key organic
acids such as succinic acid and gluconic acid contribute to kombucha’s antimicrobial activity as
well, which increases with fermentation time (Talawat et al., 2006). The increase in kombucha’s
acid content reduces the product’s pH. This along with the antimicrobial substances produced by
the bacteria and alcohol may result in curative potential (Baschali et al., 2017).
Unfermented tea and neutralized kombucha (pH = 7.0) do not display the same
antimicrobial activity as kombucha due to their lack of organic acids (Battikh et al., 2013; Ansari
et al., 2019; Greenwalt et al., 1998; Velićanski et al., 2007). Therefore, it was determined that
there is greater antimicrobial activity in kombucha than unfermented tea or neutralized tea.
Because of kombucha’s antimicrobial components, it is able to inhibit the growth of a
substantial number of pathogenic Gram-positive and Gram-negative bacteria (Jayabalan et al.,
2014; Četojević-Simin et al., 2012; Velićanski et al., 2014; Battikh et al., 2013). This includes
Agrobacterium tumefaciens, Bacillus cereus, Salmonella Typhimurium, Staphylococcus aureus,
Escherichia coli, Entamoeba cloacae, Pseudomonas aeruginosa, Aeromonas hydrophila,
Salmonella enteritidis, Shigella sonnei, Staphylococcus epidermidis, Leuconostoc
monocytogenes, Yersinia enterocolitica, Campylobacter jejuni, Helicobacter pylori,
Alicyclobacillus sp., and Micrococcus luteus (Greenwalt et al., 2000; Greenwalt et al., 1998;
Deghrigue et al., 2013; Sreeramulu et al., 2001; Mizuta et al., 2020; Sreeramulu et al., (2000). A
decent number of pathogenic yeasts were found to be sensitive to kombucha, but Candida
8

albicans and Candida krusei especially were not inhibited by kombucha (Greenwalt et al., 2000;
Greenwalt et al., 1998; Battikh et al., 2013). No antimicrobial activity against molds in
kombucha was demonstrated (Velićanski et al., 2007; Četojević-Simin et al., 2012).

1.2.3. Microbial Metabolites
D-saccharic acid-1,4-lactone, or DSL, is a microbial metabolite also known as a
postbiotic. Tea does not contain DSL because it is produced by Gluconacetobacter sp. during
fermentation as a product of the GlcUA (glucuronic acid) pathway derived from D-glucaric acid
(Jayabalan et al., 2014; Leal et al., 2018; Baschali et al., 2017). It is believed that DSL has
detoxifying, antioxidant, and antiproliferative properties (Baschali et al., 2017; Deghrigue et al.,
2013). In addition, DSL also may be a key functional component for the hepatoprotective
property in kombucha (Baschali et al., 2017; Wang et al., 2014).

1.3. Kombucha Preparation and Fermentation
Kombucha is made by using a symbiotic colony of bacteria and yeasts, or a SCOBY,
which kick-starts the fermentation process in black, green, or oolong tea sweetened by a
carbohydrate source and pre-acidified by previously prepared kombucha or acetic acid and goes
through two fermentation periods: primary fermentation and secondary fermentation (Leal et al.,
2018; Baschali et al., 2017; Greenwalt et al., 2000; Goh et al., 2012; Dufresne & Farnworth,
2000). Primary fermentation results in the production of the beverage traditionally consumed as
kombucha. Secondary fermentation is for adding sensory qualities that consumers prefer, such as
carbonation.
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1.3.1. SCOBY Growth
A symbiotic colony of bacteria and yeasts, or SCOBY, is a cellulose matrix that contains
various species of bacteria and yeasts which allows fermentation to occur (Leal et al., 2018).
Without a SCOBY, kombucha fermentation would not be possible. It acts as a catalyst, floating
on top of the tea and initiating the chemical reactions. Some of the main bacterial species
commonly found in kombucha SCOBYs include: Acetobacter spp. Gluconobacter spp.,
Komagataeibacter spp., Lactobacillus spp., and Lactococcus spp. (Blanc, 1996; Ivanišová et al.,
2020; Jakubczyk et al., 2020; Marsh et al., 2014; Villarreal‐Soto et al., 2018). Some of the main
yeast species include: Zygosaccharomyces spp., Candida spp., Saccharomyces spp.,
Saccharomycodes spp., Pichia spp., Schizosaccharomyces spp., Kloeckera spp., Torulospora
spp., and Brettanomyces spp. (Chakravorty et al., 2019; Vīna et al., 2013; Blanc, 1996; Chu &
Chen, 2006; Chen & Liu, 2000; Ivanišová et al., 2020; Liu et al., 1996; St-Pierre, 2019;
Jayabalan, Malini, et al., 2010; Kumar & Joshi, 2016; Kappel & Anken, 1993; Malbaša et al.,
2011; Jakubczyk et al., 2020; Marsh et al., 2014; Wang et al., 2014; Mayser et al., 1995;
Villarreal‐Soto et al., 2018).
As fermentation occurs, the microbes within the SCOBY reproduce, resulting in the
accumulation of a second cellulosic matrix at the air:water interface primarily produced by
Acetobacter xylinum (Chen & Liu, 2000; Leal et al., 2018; De Roos & De Vuyst, 2018; Saichana
et al., 2015; Jayabalan, Malini, et al., 2010; Villarreal‐Soto et al., 2018). This new layer of
cellulose is called the “daughter SCOBY” and is created on top of the original (or “parent”)
SCOBY. This layer can be separated from its parent SCOBY and used on its own to brew a new
batch of kombucha. However, SCOBYs are often used for multiple brewing batches before the
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freshly made daughter SCOBY needs to be separated from its parent SCOBY to be used for the
next tea brew.

1.3.2. Primary Fermentation
Primary fermentation begins by brewing black, green, or oolong tea. Once the tea leaves
are removed, a sucrose-containing carbohydrate source is added. The sweetened tea is then preacidified with previously made kombucha or acetic acid to a pH of ≤4.5 and inoculated with a
SCOBY to discourage the growth of mold (Goh et al., 2012; Brew Buch, 2020). It is not
recommended to use ceramic or metal containers for fermentation because the high acidity of
kombucha causes them to leach metals, like lead from ceramics, into the kombucha, which can
cause poisoning and even death (Gedela et al., 2016; CDC, 1995; Banerjee et al., 2010;
Smolinske, 2005). The container is then covered with a sterile, porous material such as
cheesecloth or a coffee filter to prevent insect incursion. Because the fermentation is an aerobic
process, keeping the container unsealed allows the flow of oxygen to the microorganisms within
the SCOBY that need it in order for the chemical reactions driving fermentation to occur (Huang,
2016; Blanc, 1996). Kombucha is most often fermented at ambient temperature (64-78°F or 1826°C) for 7-10 days in a dark, dry environment (Jayabalan et al., 2014; Nummer, 2013;
Greenwalt et al., 2000). Once the kombucha reaches a pH around 2.5, fermentation is often
considered complete (Nummer, 2013; Greenwalt et al., 2000; Greenwalt et al., 1998). However,
there is no definitive pH for “finished” kombucha, so the pH of the finished product is generally
determined by preference. Prolonged fermentation time leads to extreme acidity and a vinegarlike flavor (Blanc, 1996; Chen & Liu, 2000).
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During the 7-10 day fermentation period, a variety of chemical reactions are at work to
transform tea into kombucha (Figure 1.1). Yeast species in the SCOBY, such as
Zygosaccharomyces rouxii, Brettanomyces bruxellensis, Saccharomyces cerevisiae,
Schizosaccharomyces pombe, Torulospora delbrueckii, Kloeckera apiculata,
Zygosaccharomyces bailii, Saccharomycodes ludwigii, and Pichia membranaefaciens, use the
sugar in the tea as fuel and break down the sucrose into the monosaccharides glucose and
fructose by yeast invertase (Chakravorty et al., 2019; Chen & Liu, 2000; St-Pierre, 2019; Leal et
al., 2018; Jayabalan, Malini, et al., 2010; Kappel & Anken, 1993; Jakubczyk et al., 2020; Wang
et al., 2014; Mayser et al., 1995; Villarreal‐Soto et al., 2018). The glucose and fructose are then
converted into ethanol via glycolysis, with a preference for consumption of fructose as a
substrate (Jayabalan et al., 2014; Huang, 2016; Leal et al., 2018). Additionally, carbon dioxide is
released as a byproduct of the yeast breaking down the sucrose. Acetic acid bacteria, including A.
xylinum, Acetobacter pasteurianus, and Acetobacter aceti, convert the ethanol created by the
yeast into acetic acid as well as converting the glucose into gluconic acid (Huang, 2016; Chen &
Liu, 2000; Liu et al., 1996; Leal et al., 2018; Banerjee et al., 2010; Sievers et al., 1995). Notably,
ethanol to acetic acid conversion happens only in the presence of oxygen. Lactic acid bacteria
convert any remaining sugars into lactic acid.
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Figure 1.1. Chemical Reactions During Kombucha Fermentation
Since this is an aerobic process, none of the chemical reactions can occur in a closed
system, such as in a jar with an airtight lid, because the yeasts and acetic acid bacteria require
oxygen to produce their hydrolyzing enzymes (yeast invertase) and byproducts (Leal et al., 2018;
De Roos & De Vuyst, 2018; Saichana et al., 2015; Gullo et al., 2014). At the end of an average
fermentation period (7-10 days), studies have shown there is an overall increase in organic acids
(acetic acid, glucuronic acid, gluconic acid, etc.), DSL, amino acids, vitamins, minerals, and
ethanol while sucrose decreases (Figure 1.2) (Neffe-Skocińska et al., 2017; Chen & Liu, 2000;
Jayabalan, Malini, et al., 2010; Lončar et al., 2000; Jayabalan et al., 2007; Bauer‐Petrovska &
Petrushevska‐Tozi, 2000; Kaewkod et al., 2019).
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Figure 1.2. Beneficial compounds produced at the end of primary fermentation

1.3.2.1. Different Sugar and Tea Substrates
Black, green, and oolong tea are the most commonly used teas for kombucha production, but
there are many studies using other varying tea types such as purple basil, Zijuan, lemon balm,
white, red, and rooibos (Yıkmış & Tuğgüm, 2019; Zou et al., 2021; Gaggìa et al., 2019; Ansari et
al., 2019; Velićanski et al., 2007; Velićanski et al., 2014; Četojević-Simin et al., 2012). All teas
proved to be successful in kombucha fermentation and generally yield beverages well-accepted
by consumers. Additionally, they were all revealed to have an equal or better phenolic,
antioxidant, flavonoid, and/or antimicrobial properties than traditional kombucha, except for
rooibos tea kombucha. The rooibos kombucha did not have as high an antioxidant activity as
black and green tea kombucha, but it showed an important effect on the recovery of oxidative
damage (Gaggìa et al., 2019).
Kombucha may not strictly use white granulated sugar as its carbohydrate source during
fermentation. Brown sugar, molasses, maple syrup, coconut palm sugar, and more can also be
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used, but white sugar is most commonly used and often preferred. The use of different sugars
will result in different flavor profiles and metabolites produced because each source has a
different amount of sucrose available to be broken down into subsequent metabolites via
chemical reactions during fermentation (Chen & Liu, 2000). Studies have shown the use of
alternative sugar sources are successful in producing a sweetened kombucha-style beverage
(Muhialdin et al., 2019; Perry et al., 2020; Malbaša, Lončar, & Djurić, 2008; Malbaša, Lončar,
Djurić, & Došenović, 2008). The coconut palm sugar took it a step further in producing
kombucha with the highest antioxidant activity and total phenolic content when compared to
kombucha made with white refined sugar and molasses sugar (Muhialdin et al., 2019).

1.3.3. Secondary Fermentation
Secondary fermentation allows flavor and carbonation to be incorporated into the
beverage. The SCOBY is removed from the container, and any flavorings and/or fruits are added
to the liquid broth. Residual microorganisms present in the fermentate metabolize the sugars
present in the added fruit/juice to yield carbon dioxide. This step is performed in a sealed vessel
in order to retain the CO2 produced. Secondary fermentation is not mandatory to produce
kombucha, but it is preferred by consumers, so many commercial brewers opt to do it. Taste is
the most influential factor in consumers’ food choices, and the flavorings aid in combatting the
overly acidic, vinegar-like taste (Siró et al., 2008; Urala & Lähteenmäki, 2003).
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1.3.4. Microorganisms Present in the Finished Beverage
Many of the organisms in the SCOBY can be found in the finished product. Yeasts and
acetic acid bacteria make up a majority of these organisms. This includes Zygosaccharomyces
bailii, Brettanomyces bruxellensis, Saccharomyces cerevisiae, Schizosaccharomyces pombe,
Torulospora delbrueckii, Torulopsis sp., Kloeckera sp., Candida sp., and Pichia sp. for yeast
species and A. xylinum, A. pasteurianus, A. aceti, Gluconobacter sp., and Komagataeibacter sp.
for acetic acid bacteria species (Liu et al., 1996; Teoh et al., 2004; Steinkraus et al., 1996; Reva
et al., 2015).

1.4. Probiotic Presence in Kombucha
The FAO/WHO defines probiotics as “live microorganisms that when administered in
adequate amounts are able to provide benefits to the health of the consumer” (2001). These
health benefits can involve either direct or indirect interactions with the gut microbiota (Tur &
Bibiloni, 2016). Lactobacillus and Bifidobacterium species are the most commonly used
probiotics in commercial foods. Other probiotics include certain strains of Lactococcus spp.,
Enterococcus faecalis, Enterococcus faecium, Leuconostoc, and yeast, but they are not as wellknown or used as often (Diez-Gutiérrez et al., 2020; Tripathi & Giri, 2014; Marsh et al., 2014).
As of 2014, Saccharomyces boulardii is the only recognized probiotic yeast (Marsh et al., 2014).
Approved probiotics are classified as generally recognized as safe, or GRAS, because of their
very low probability of causing human infection (Diez-Gutiérrez et al., 2020). Over the years,
people have become more conscious of their health and know that food and eating habits have a
large impact, so as a result, the demand for probiotic functional foods has increased dramatically.
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At the moment, probiotic foods are the most reasonable, practical, and popular way to ingest
your daily dose of probiotics (Tripathi & Giri, 2014).
Probiotics provide numerous health benefits, but these benefits can only be realized when
a food contains the minimum effective dose of viable or heat-killed probiotic cells at
consumption. This minimum, recommended by the Food and Drug Administration (FDA) and
adopted by the food industry, is set at a minimum level of 106 CFU/mL at the time of
consumption (Tripathi & Giri, 2014). However, this may not be enough to receive the full effects
of some probiotics. It is recommended that a daily intake of probiotic foods or beverages
containing 108 – 109 viable cells should be consumed in order for the probiotic to reach the
intestine, although necessary dosage varies considerably depending on strain (Tripathi & Giri,
2014; Marsh et al., 2014). Since probiotics are not retained in the gut, regular consumption is
needed to maintain the claimed health benefits (Tur & Bibiloni, 2016).
First and foremost, the most important job of a probiotic is to maintain a healthy
intestinal microbiota by protecting the gut against gastrointestinal pathogens. Additionally,
certain probiotics have been shown to alleviate lactose intolerance, enhance the immune system,
reduce high cholesterol and blood pressure levels, have anti-carcinogenic properties, improve
utilization of nutrients, and improve the nutritional value of food (Tur & Bibiloni, 2016; Tripathi
& Giri, 2014; Baschali et al., 2017). Regardless of all these health benefits, the FDA currently
does not support probiotic health claims, yet it does agree with the claim that probiotics may aid
in disease prevention. The reason the FDA does not currently support probiotic health claims
may be due to the lack of international regulations for probiotic products (Diez-Gutiérrez et al.,
2020).
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1.4.1. Supposed Probiotics Present in Kombucha: Lactic Acid Bacteria
A majority of the microorganisms present in a kombucha SCOBY have not demonstrated
probiotic activity. As a result, commercial probiotic strains, such as Bacillus coagulans, are often
added to the beverage post-fermentation in order to claim it is a probiotic beverage. Just
consuming live organisms does not necessarily confer a benefit, contrary to what many
consumers tend to believe. Therefore, it is important to identify the live organisms in finished
kombucha and incorporate any proven probiotics if a probiotic beverage is desired.
Lactic acid bacteria, or LAB, are known to be a part of kombucha’s microbial makeup
and can possibly act as probiotics. Although many probiotics are categorized under the umbrella
of “lactic acid bacteria”, not all LAB are probiotics. Even members of the same species may
differ in their probiotic potential. LAB strains can vary from culture to culture and batch to batch
in regard to which species can be found in the SCOBY, so it is unknown which strains are
present in one particular batch of kombucha unless the brewer has added additional commercial
probiotics of a known strain to the batch or if analysis of the microbial community is performed.
LAB have GRAS status and possess special physiological activities that make them very
appealing to the food industry. They have been utilized extensively as probiotics in dairy
products, bread, fermented vegetables, meats, fish, etc. because of their notable properties such
as immunomodulation, inhibition of pathogenic bacteria, control of intestinal homeostasis,
resistance to gastric acidity, bile acid resistance, and anti-allergic activity (Li & Cao, 2010; Cui
et al., 2020). Moreover, as a probiotic in foods, LAB have the capability to extend shelf life,
enhance safety, improve the texture, and add to a desirable sensory profile (Li & Cao, 2010).
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1.5. Storage
There are several different ways kombucha is preserved and stored. The most common
method is to use a combination of refrigeration and antifungal preservatives (0.1% sodium
benzoate and 0.1% potassium sorbate) (Nummer, 2013; Leal et al., 2018). This ensures
foodborne hazards and spoilage are minimized by preventing spoilage organism growth and
keeping yeast growth at a minimum. Many commercial cultures today will contain yeasts that do
not grow well at refrigeration temperatures so that once bottled, the carbon dioxide and alcohol
production will be minimized (Nummer, 2013). Otherwise, this is a major concern; yeasts
unaffected by refrigeration temperatures will continue to produce carbon dioxide and alcohol,
thus threatening explosion of the bottles and raising the alcohol content to a level where it needs
to be labeled as a full-alcoholic beverage rather than a low-alcohol beverage. As mentioned
previously, kombucha does contain traces of alcohol, but it is considered to be a low-alcohol
beverage. Legally, “low-alcohol” or “reduced alcohol” beverages must contain less than 2.5%
ABV and this terminology can be used only on malt beverages (27 CFR § 7.71, n.d.). However,
under federal law if kombucha’s alcohol content is ≥0.5% ABV at any point during production,
it must be sold and regulated according to the Alcohol and Tobacco Tax and Trade Bureau
(TTB) as an alcoholic beverage (TTB, 2017).
While relying on refrigeration alone is often a preferred method for homebrewers, using a
combination of preservative treatments is the most effective way to ensure the required amount
of protection needed for commercial kombucha to retain its sensory qualities, such as color,
texture, flavor, and nutritional value (Nummer, 2013; Brul & Coote, 1999). Filtration is another
method sometimes used by commercial brewers to clarify and stabilize the beverage for storage
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by physically removing the majority of the yeast cells before bottling (Rektor & Vatai, 2004;
Peña-Gómez et al., 2020).
Pasteurization of bottled kombucha is another common preservation method because
pasteurized kombucha is shelf stable at room temperature so long as the product has a pH of 4.2
or below (Nummer, 2013; Leal et al., 2018). However, pasteurization kills any “good
microorganisms” present in the liquid rendering any potential health benefits involving the
consumption of these beneficial microorganisms null. As a result, it is not uncommon for
commercial producers to add probiotics to the finished beverage especially after pasteurization to
restore those benefits lost from killing off the “good microorganisms” (Figure 1.3). Based on
Jayabalan et al. (2008)’s study, it was determined that heat treatments of ≥60°C for one minute
or longer were not ideal for kombucha preservation because there was a degradation of the tea
components and a steady decrease in the beverage’s free radical scavenging properties during the
90-day storage period.
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Figure 1.3. KeVita’s Pasteurized Kombucha Bottle and Label
Label indicates live probiotics (Bacillus coagulans MTCC 5856) were added and this bottle has a
0.5% ABV content.

1.6. Key Characteristics of Kombucha Make It Unlikely for Harmful Microorganism
Survival
Kombucha has unique characteristics unlike most other foods and beverages that allows
only specific groups of microorganisms to survive and thrive. The chemical composition of
kombucha, the high acidity levels, and the high microbial load providing ample competition for
resources significantly contribute to this environment.
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1.6.1. Chemical Composition
Kombucha’s chemical composition consists of numerous components that deter
potentially harmful microorganisms from surviving or thriving in the liquid. Various organic
acids, including acetic acid, lactic acid, gluconic acid, glucuronic acid, citric acid, malic acid,
tartaric acid, malonic acid, oxalic acid, succinic acid, pyruvic acid, and usnic acid, make up the
majority of kombucha’s composition which lowers the beverage to a pH where many harmful
molds, yeasts, and other microorganisms cannot survive (Blanc, 1996; Neffe-Skocińska et al.,
2017; Chu & Chen, 2006; Chen & Liu, 2000; Ivanišová et al., 2020; St-Pierre, 2019; Leal et al.,
2018). Kombucha also contains polyphenols (catechin and isorhamnetin), D-saccharic acid-1,4lactone (DSL), carbon dioxide, vitamins, and [low levels of] alcohol (ethanol, glycerol), which
contribute to suppressing bacterial growth and/or have antimicrobial properties (Deghrigue et al.,
2013; Tarver, 2016; Chatterjee et al., 2006; Daniels et al., 1985; Bhattacharya et al., 2020;
Bhattacharya et al., 2016).
Many of these components are used as natural or added preservatives for numerous foods
and beverages. They are necessary to extend shelf-life, deter unwanted microbial growth and
spoilage, and ensure the safety of the product. Weak organic acids, such as acetic acid, lactic
acid, benzoic acid, and sorbic acid, are the most common classical preservative agents. Other
common food preservatives consist of phenolics and alcohol, all of which can be found in
kombucha (Brul & Coote, 1999). These preservatives have an optimal inhibitory activity at a low
pH and the ability to inhibit the outgrowth of bacterial and fungal cells (Brul & Coote, 1999).
While bacterial spores are not killed by any of these preservatives, phenolics, organic acids, and
alcohol are able to inhibit spore germination as well as the growth of vegetative bacteria
(Russell, 1991). Carbon dioxide is inhibitory to many food spoilage organisms, including
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psychrotrophs, thus ensuring no contamination of psychrotrophic food spoilage organisms in the
kombucha during refrigeration and storage (Russell, 1991).

1.6.2. Acidity
The multitude of organic acids found in kombucha, especially acetic acid, not only act as
preservative agents but they also contribute to kombucha’s high acidity levels. The finished
product of kombucha usually has a pH of about 2.5 (Nummer, 2013; Greenwalt et al., 2000;
Greenwalt et al., 1998). Very few microorganisms are capable of surviving at such low pH
levels. Acetic acid bacteria, Acetobacter and Gluconobacter spp., and lactic acid bacteria,
Lactobacillus, and Leuconostoc spp., thrive at pH levels as low as 3.5 whereas other bacteria
such as Lancefield Group N streptococci, Clostridium butyricum and C. pasteurianum, Bacillus
acidoterrestris, B. coagulans, B. macerans, and B. polymyxa can only tolerate, but not increase
in population, at these pH levels (Booth & Stratford, 2003; Ray, 2004). A considerable amount
of other bacteria will not grow below pH 4.5. This low pH environment may not necessarily kill
the bacteria, but it will prevent its growth. The combination of low pH and a high weak acid
concentration in an environment often leads to the acidification of the bacteria’s cytoplasm,
which is usually enough to halt microbial growth (Booth & Stratford, 2003).
Most food spoilage organisms and foodborne pathogens grow within a pH range of 4.08.0. This does not account for spoilage yeasts and molds which are able to grow and survive at
lower pH levels (Booth & Stratford, 2003). With consumable kombucha consistently at pH under
4, and oftentimes significantly lower, spoilage yeasts, molds, and spore-formers are more of a
concern than harmful vegetative bacteria. However, bacterial spores are not able to germinate at
a pH less than 4.5 (Booth & Stratford, 2003). The few organisms capable of growing outside
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these pH ranges have never presented a significant food spoilage problem in the past because
there are seldom truly acid-resistant organisms found naturally in foods (Booth & Stratford,
2003).
Acid shock syndrome is also a very common occurrence when organisms adapted to a
near neutral or basic pH are suddenly thrown into an acidic environment. When placed into an
environment with a pH of 3.5 or below, bacteria are killed rapidly (Booth & Stratford, 2003).
Many different organisms are capable of enhancing their “acid tolerance” by previous exposure
and growth at mildly acidic conditions (pH of 4.5-6). This is known as a bacterium’s acid
tolerance response (ATR) (Booth & Stratford, 2003; Browne & Dowds, 2002). Several
organisms such as Escherichia coli, Salmonella Typhimurium, Yersinia, Listeria monocytogenes,
and Lactobacillus have been found to demonstrate strong ATR responses (Booth & Stratford,
2003). Such responses can be concerning in long-duration fermentations if the pace of
acidification is slow enough to permit adaptation.

1.6.3. Microbial Competition
Because of the abundance of bacterial and yeast species present in kombucha, a very
competitive environment is created, allowing no other bacterial, fungal, or spoilage species room
or resources to invade. In this sense, already-present bacterial and yeast species practice
competitive exclusion. Together they exhibit metabolic cooperation, where one species
metabolizes a nutrient and their byproducts are utilized by another species, which increases their
reliance on one another and strengthening their community rather than if a species were alone
(Elias & Banin, 2012). In several studies regarding multi-species vs. mono-species biofilms, the
mixed-species biofilm in most cases was considerably more resistant to invaders (Elias & Banin,
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2012). The less “good” microorganisms already present, the more chances for possible
pathogenic contamination.
Acidity and the number of possible pathogenic microbial cells have an inverse
relationship in kombucha. When kombucha’s acidity increases due to the organic acids produced
during fermentation, there is a lack of oxygen present in the liquid, resulting in a decrease of
aerobic bacteria (Leal et al., 2018). The ethanol and acetic acid produced by yeasts, Acetobacter,
and Gluconobacter contribute to inhibiting the growth of pathogenic bacteria and might prevent
competition from other microorganisms (Liu et al., 1996; Leal et al., 2018; De Roos & De Vuyst,
2018; Saichana et al., 2015). Heat treatments that are known to reduce competitive microbiota in
kombucha have been shown to support the growth of vegetative bacterial cells as well as the
germination of bacterial spores (Bacillus cereus—BfR, n.d.).
When evaluating all these factors simultaneously, kombucha demonstrates the
unlikeliness of foodborne pathogen contamination. However, because of this there is little to no
research being pursued on potential contamination that could occur throughout the brewing
process or with varying types and severities of foodborne pathogens.

1.7. Safety Concerns of Kombucha
Several sporadic cases have been reported where people consumed kombucha and shortly
after have, allegedly, fallen ill, been hospitalized, and even died because of it. This raised great
concern for kombucha drinkers, and people began to wonder if kombucha was safe to consume.
However, these cases are rare and spread out over the course of 20 years with the last case being
in 2017 (Holbourn & Hurdman, 2017; Murphy et al., 2018). Most of these cases involved
individuals with underlying health issues who then drank an excessive amount of kombucha
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within a short amount of time, leading to serious health problems like acidosis, hepatotoxicity,
renal failure, etc. (Gedela et al., 2016; SungHee et al., 2009; CDC, 1995; Holbourn & Hurdman,
2017; Srinivasan et al., 1997; Phan et al., 1998; Kovacevic et al., 2014). Medical professionals
deduced that it was the only logical conclusion that kombucha must have been the cause of these
illnesses, yet no definitive direct link can be established. As of 2009, there have been no cases
reported determining that “a clinically significant bacterial or fungal infection” of an individual
was caused by kombucha directly (SungHee et al., 2009). However, the FDA has not ruled out
the possibility of fungal contamination in kombucha that is known to cause disease in susceptible
individuals (SungHee et al., 2009).
Because kombucha consumption has proven to be harmful in only a few documented
instances, the CDC recommends an individual should not consume more than 4 oz per day at a
pH no higher than 4.2 (which may allow for mold growth) or no lower than 2.5 (too acidic)
(Nummer, 2013). Drinking excessive amounts of kombucha in a short period, especially at a pH
of ≤2.5, could cause acidosis (SungHee et al., 2009; CDC, 1995; Baschali et al., 2017;
Petruzzello, n.d.). By not over-fermenting kombucha brews and limiting servings, the CDC
suggests that kombucha is a fairly safe product fit for consumption (Nummer, 2013). To date, the
FDA has not found any pathogenic organisms or hygienic violations in the practices of the
commercial manufacturers of this product (Nummer, 2013; Gedela et al., 2016). On the contrary,
home brewing of kombucha is conducted under varying conditions, without strict sanitation
controls and therefore, homebrews are more likely to be contaminated with pathogenic
organisms like Aspergillus and cause illness (CDC, 1995; Srinivasan et al., 1997). This also
could occur due to improper technique (such as not pre-acidifying the sweetened tea before
fermentation with previously prepared kombucha or not taking pH measurements to know when
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to end fermentation), misuse of equipment (such as mishandling of SCOBY or using the wrong
container type), or being uneducated about kombucha and the fermentation process. For
example, if homebrewers prepare or store their brews in ceramic or lead containers, toxic
material can leach into the tea because of the high acidity (Gedela et al., 2016; SungHee et al.,
2009; CDC, 1995; Srinivasan et al., 1997). Unwashed fruit used for secondary fermentation may
introduce various soilborne microorganisms including fungi and bacterial spores.
In 1996, there was a documented case of twenty people contracting cutaneous anthrax after
applying a kombucha SCOBY to the skin as a topical painkiller (Smolinske, 2005; Watawana et
al., 2015; Sadjadi, 1998). Bacillus anthracis was identified as the culprit, and seeing as it is a
spore-former, it is possible Bacillus spores are capable of becoming associated with kombucha
SCOBYs. The cause of contamination was determined to be the unhygienic preparation of the
tea in plastic containers in a farmyard in close proximity to cattle (Watawana et al., 2015;
Sadjadi, 1998).
It is recommended by the CDC and other various sources that people with pre-existing
health conditions should not consume [unpasteurized] kombucha because of the wide variety of
microorganisms it contains. Potential health risks are unknown for those who have pre-existing
health problems or drink excessive amounts of kombucha, and the cases in literature suggest
adverse effects are more likely to occur in these circumstances (Nummer, 2013; Srinivasan et al.,
1997).
Even after bottling, biochemical processes can continue to occur in kombucha, leading to
carbon dioxide pressure buildup in a closed container. Because the pressure has nowhere to
escape, the buildup could potentially cause leakage or explosion of the packaging, threatening
projectile hazards (Nummer, 2013). The best prevention method would be to pasteurize the
27

product, killing any active microorganisms, thus halting any biochemical processes (Nummer,
2013). As a result, the carbon dioxide pressure buildup is prevented, but the potential health
benefits from the live organisms are no longer available.

1.7.1. Amino Acid and Biogenic Amine Presence in Kombucha
The presence of amino acids in a food product is usually a positive attribute since amino
acids are essential to proper bodily function. However, these amino acids can often be
transformed into biogenic amines via microbial decarboxylation during fermentation. Some
biogenic amines are beneficial while others can be harmful to humans if ingested in high enough
concentrations, such as histamine (Santos, 1996; Ruiz-Capillas & Herrero, 2019). The formation
of biogenic amines is also influenced by the raw materials used, the microorganisms present in
the starter culture, and processing and storage conditions (Doeun et al., 2017; Ruiz-Capillas &
Herrero, 2019). While consuming low amounts of biogenic amines normally does not have a
harmful effect on human health, their levels are often elevated to toxic amounts in fermented
foods (Doeun et al., 2017). On the other hand, beneficial metabolites, such as gammaaminobutyric acid, can also be produced during fermentation (Section 1.8).
The biogenic amines found in food that pose the biggest threats for foodborne poisoning
and illness include histamine, tyramine, putrescine, cadaverine, β-phenylethylamine, agmatine,
tryptamine, serotonin (SRT), spermidine, and spermine (Santos, 1996; Ruiz-Capillas & Herrero,
2019; Shalaby, 1996). Scombroid poisoning, or histamine poisoning, is caused when too much
histamine is consumed and is most associated with fish, but outbreaks have also occurred with
cheese, wine, and meat products (Santos, 1996). Symptoms of scombroid poisoning include
dizziness, faintness, burning sensation in the mouth, inability to swallow, and itching
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(Hungerford, 2010). Putrescine and cadaverine are responsible for enhancing the toxicity of
histamine (Tabanelli, 2020). Overconsumption of tyramine, phenylethylamine, and tryptamine
leads to hypertension, headaches, pupil dilatation, palpebral tissue dilatation, and respiration
increasing (Shalaby, 1996). Spermine and spermidine have been shown to help lower blood
pressure, inhibit blood clotting, provoke respiratory symptoms, and reduce neurotoxicity which
induced renal insufficiency (Pegg, 2013).
Many scholarly articles and reviews on kombucha discuss its chemical composition and
what it consists of, which includes amino acids and biogenic amines, however, there is seldom
any in-depth literature on specific amino acids and biogenic amines that can be found in
kombucha. There is some research on amino acids and biogenic amines that have been found
within the SCOBY or “tea fungus” but none on which constituents can be found in the broth,
which is the portion consumed. The SCOBY was found to contain higher concentrations of
lysine, isoleucine, and leucine and lower concentrations of phenylalanine, valine, methionine,
threonine, tryptophan, glutamic acid, alanine, aspartic acid, and proline (Leal et al., 2018). Of
these amino acids, only lysine, phenylalanine, and tryptophan are precursors for the
aforementioned harmful biogenic amines (Doeun et al., 2017; Santos, 1996). However,
ethylamine, choline, and adenine were the only identifiable biogenic amines in kombucha that
were discussed in literature, none of which are harmful (Kappel & Anken, 1993).

1.8. GABA
Gamma-aminobutyric acid, or GABA, is a nonprotein amino acid that acts as a
postbiotic, or a bioactive compound produced by probiotic metabolism, and is produced by
plants, animals, and microorganisms, including fungi, yeast, and bacteria (Bown & Shelp, 1997;
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Shelp et al., 1999; Diez-Gutiérrez et al., 2020; Cui et al., 2020). It is converted from glutamic
acid via glutamic acid decarboxylase (GAD) into two isoforms, GAD65 and GAD67 (Ting
Wong et al., 2003). GABA is well-known as a major inhibitory neurotransmitter in the central
nervous system and operates via the brain-gut connection (My, 2018; Diez-Gutiérrez et al., 2020;
Cui et al., 2020). Lactic acid bacteria can disable food spoilage pathogens from growing in foods
by producing GABA in the presence of glutamic acid, while also acting as probiotics in the
gastrointestinal tract once consumed (My, 2018; (Diez-Gutiérrez et al., 2020; Dhakal et al.,
2012).
GABA is said to have a wide variety of beneficial health effects. It is most known for its
roles in regulating hypertension, moderating neurological disorders, such as epilepsy,
schizophrenia, Alzheimer’s disease, and aiding in alleviating psychiatric disorders, such as
anxiety, stress, sleeplessness, depression, alcoholism, and mood (Diez-Gutiérrez et al., 2020;
Sang et al., 2018; Ting Wong et al., 2003; Shimada et al., 2009; Inoue et al., 2003; Aoki et al.,
2003; Yoto et al., 2012; Nakamura et al., 2009; Abdou et al., 2006; Byun et al., 2018; Petty,
1995; Seidl et al., 2001; Opolski et al., 2000). In addition, the postbiotic helps protect against
cancer, enhances immunity and vital organ function, aids in preventing diabetes, and acts as a
hormonal regulator and potential antioxidant (Sang et al., 2018; Oh & Oh, 2003; Adeghate &
Ponery, 2002; Oh & Oh, 2004; Opolski et al., 2000; Schuller et al., 2008; Sasaki et al., 2006;
Leventhal et al., 2003; Wiens & Trudeau, 2006). In fermented foods specifically, GABA aids
with gut microbiota dysbiosis reversal, neurostimulation, and cardioprotection (Diez-Gutiérrez et
al., 2020).
Chemical synthesis of GABA was originally used to meet the demand for it as a
supplement, however it has since been replaced by the use of microorganisms. By using
30

microorganisms such as lactic acid bacteria to produce GABA, yields are higher, costs are
lowered, and the use of corrosive reagents is excluded (Diez-Gutiérrez et al., 2020). As of 2008,
the FDA granted GABA generally recognized as safe (GRAS) status (PubChem, n.d.; FDA,
n.d.).
Temperature, pH, fermentation time, and different media additives are the main
environmental factors that affect GABA production throughout fermentation because they
modulate the gad gene expression, which controls GABA production (Diez-Gutiérrez et al.,
2020; Dhakal et al., 2012). These circumstances are different depending on which strain is being
utilized, but studies show the ideal temperature and pH for optimal GABA production is between
30-40°C and 4.5-6.0, respectively (Diez-Gutiérrez et al., 2020; Dhakal et al., 2012; Sang et al.,
2018). Since glutamic acid needs to be present for the production of GABA, foods such as
Korean kimchi, Chinese paocai, yogurt, cheese, and sourdough are ideal for GABA-producing
LAB growth (Sang et al., 2018).

1.9. Bacillus cereus as a Foodborne Pathogen
1.9.1. Gram-positive bacteria and Spore-formers
Some Gram-positive bacteria, known as spore-formers, have ability to produce
endospores under stressed conditions such as extreme pH, extreme temperature, drought, and
lack of proper nutrients. This process is called sporulation (Karki, 2017). Examples of sporeformers include Bacillus spp., Clostridium spp., and Sporosarcina spp. (Karki, 2017). When
sporulation occurs, the vegetative cell forms in a hardened seed-like structure containing the
DNA of the bacterium and becomes metabolically dormant (Figure 1.4) (Karki, 2017).
Endospores can stay in this state for years and years and are resistant to nutrition starvation,
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temperature, extreme pH, antibiotics, radiation, etc. (Karki, 2017; Kotiranta et al., 2000). Some
mature spores may even survive various food production procedures such as pasteurization,
heating, and gamma radiation that act as “fail-safes” to rid foods of harmful pathogens (Kotiranta
et al., 2000). Once nutrients are available, the spores are then activated and return to their full
vegetative cell state again (Figure 1.4). This process is called spore transformation (Aissa
Ouaissi Sekkouti, 2019).
Spore-formers can be found everywhere in the environment, and their wide range of
diversity leads to their natural prevalence in foods. Consequently, it is not unrealistic or
impossible for spores to be found on or in foods and food ingredients at any stage of food
production (Stenfors Arnesen et al., 2008).

Figure 1.4. Spore Transformation Cycle of Bacillus spp. Including Sporulation and
Germination
Adapted from McKenney et al. (2013).
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1.9.2. Bacillus cereus Pathogenicity and Illnesses
Bacillus cereus is a Gram-positive bacillus, spore-forming foodborne pathogen that, out
of the Bacillus genus, is the species most associated with food. As a normal soil inhabitant, B.
cereus is frequently found in the environment, in soil samples and vegetation, and is commonly
isolated from foods (Granum & Lund, 1997). B. cereus spores have been known to adhere to
stainless steel pipes and tanks, which presents a serious challenge since stainless steel is the most
commonly used material for food industry equipment (Wijman et al., 2007). B. cereus is also
capable of forming biofilms, enabling the organism to persist in food production environments
(Bacillus cereus—BfR, n.d.). Being a facultative anaerobe, B. cereus is able to survive an
environment with or without oxygen, indicating that it is capable of surviving through various
processes including fermentation (Examining Food, 2013). As a mesophilic organism, B.
cereus’s optimum growth temperature is between 35-40°C, but it is capable of growing from
10°C to 50°C, which includes the temperature at which fermentation of kombucha takes place
(Stenfors Arnesen et al., 2008). In the last few decades, the number of psychrotolerant B. cereus
strains, or strains tolerant to colder temperatures, have increased, making it more of a risk to food
safety than ever before (Stenfors Arnesen et al., 2008).
It was not until Hauge’s experiments in the 1950s, after investigation into outbreaks in
Norway hospitals from 1947-1949 caused by an unknown source, that B. cereus was established
as an organism capable of causing foodborne diseases (Drobniewski, 1993; Stenfors Arnesen et
al., 2008). Today, there are around 64,000 cases of illnesses caused by B. cereus reported
annually, but this number is most likely underreported. This is due to the short duration of the
illness, the mild symptoms, and misdiagnosis (Examining Food, 2013; Ding et al., 2013; Stenfors
Arnesen et al., 2008). Symptoms generally resolve within 24 hours and are mild enough that a
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hospital visit is not often required, and fatality is rare (Shinagawa, 1990; Notermans & Batt,
1998; Kotiranta et al., 2000). Cases of B. cereus gastroenteritis of food origin also seem to be on
the rise in more industrialized countries such as Korea, Germany, Finland, and the United States
(Ding et al., 2013).
There are two types of illnesses associated with B. cereus: emetic and diarrheal. The
emetic illness is frequently confused for Staphylococcus aureus intoxication while the diarrheal
illness is often mistaken for Clostridium perfringens food poisoning because they have
overlapping symptoms and resemble one another (Shinagawa, 1990; Stenfors Arnesen et al.,
2008). The emetic illness is an intoxication, meaning toxin(s) is produced within the food by the
bacteria, and illness occurs when that toxin is consumed (Bacillus cereus—BfR, n.d.; Ministry of
Agriculture and Forestry of Alberta, Canada, 2006). Bacillus cereus was identified in the early
1970’s in the United Kingdom after several outbreaks were determined to be caused by
consumption of contaminated cooked rice (Stenfors Arnesen et al., 2008). Emetic illness is
associated with nausea, vomiting, and malaise starting 1-5 hours after ingestion and usually
lasting 6-24 hours (Bacillus cereus—BfR, n.d.; Notermans & Batt, 1998; Kotiranta et al., 2000).
Foods most associated with emetic illness are starchy foods such as pasta, fried rice, and cooked
rice (Notermans & Batt, 1998; Ding et al., 2013; Stenfors Arnesen et al., 2008). The illness is
caused by the emetic toxin pre-formed in food; spores not killed off by cooking processes
germinate in food during instances of temperature abuse, and cereulide, a small ring-shaped
dodecadepsipeptide that acts as the emetic toxin, forms in the food as the vegetative cells grow
(Bacillus cereus—BfR, n.d.; Shinagawa, 1990; Stenfors Arnesen et al., 2008). Cereulide is
extremely resistant to factors such as low pH, heat, and proteolysis. However, only a small
percentage of B. cereus strains are capable of producing cereulide (Bacillus cereus—BfR, n.d.).
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The infectious dose of emetic-toxin producing B. cereus causing illness in half of those infected
(ID50) has not yet been determined, although foods involved in cases of emetic disease have had
levels of cells ranging from 103-1010 CFU/g with at least 105 CFU/g food in most cases (Stenfors
Arnesen et al., 2008).
The diarrheal illness is a toxicoinfection, meaning the illness is caused by toxins
produced by the bacteria after consumption (Bacillus cereus—BfR, n.d.; Stenfors Arnesen et al.,
2008; Ministry of Agriculture and Forestry of Alberta, Canada, 2006). It is most associated with
abdominal pain, cramps, and watery diarrhea occurring 8-16 hours after ingestion of
contaminated food and generally resolves within 12-24 hours (Bacillus cereus—BfR, n.d.;
Notermans & Batt, 1998; Kotiranta et al., 2000). The minimal ID50 for the diarrheal type illness
has been established as a range between 105-108 B. cereus cells, however doses as low as 103 B.
cereus CFU/g of food have been identified in foods causing disease (Stenfors Arnesen et al.,
2008). Foods most associated with diarrheal illness are proteinaceous foods, sauces, desserts,
vegetables, and dairy products (Notermans & Batt, 1998; Ding et al., 2013; Stenfors Arnesen et
al., 2008). In recent years, psychrotrophic diarrheal strains have become an increasing problem
for the dairy industry (Granum & Lund, 1997). Diarrheal illness is caused by an enterotoxin
produced by vegetative B. cereus cells in the small intestine. Unlike cereulide, however, the
enterotoxin is sensitive to heat, acid, and proteolysis (Bacillus cereus—BfR, n.d.; Ding et al.,
2013).
Various mutant strains of B. cereus exist that are able to survive in extreme heat and/or
acidic conditions (Bacillus cereus—BfR, n.d.). There are several strains of B. cereus known to
flourish at both extremes of the pH scale, ranging from pH 2 to 10 (Drobniewski, 1993).
However, it is a rare occurrence to have vegetative cells survive in foods that are dry and/or
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acidic, although this does not apply for spores (Bacillus cereus—BfR, n.d.). Spores of certain B.
cereus strains are adept at tolerating foods at high temperatures with a high fat content as this
acts as an added level of protection (Drobniewski, 1993; Johnson, 1984).
Illness due to B. cereus is most likely to occur from foods left out at room temperature for
a prolonged time (emetic) or from improper storage of foods (diarrheal) (Examining Food,
2013). It only takes >104 CFU/g of B. cereus cells for foods to be considered potentially unsafe
for consumption (Ding et al., 2013). As a result, it is not unreasonable or uncommon for
outbreaks to occur. Inadequate cooking, inadequate cooling, preparation of food too far in
advance, and infected personnel are important factors in contributing to foodborne outbreaks,
with inadequate cooling deemed the most important factor causing disease outbreaks (Johnson,
1984). If storage temperature conditions are poorly controlled, the possibility of spore
germination and multiplication of vegetative cells in the stored food increases dramatically.
Nonetheless, this can be easily prevented by the rapid cold or hot storage of heated foods
(Bacillus cereus—BfR, n.d.). B. cereus strains also demonstrate a poor ability to grow at
temperatures below 10°C, resulting in a low spore germination rate (Carlin et al., 2006). By
practicing good hygiene and food preparation practices, the incidence of gastrointestinal disease
can be significantly reduced, especially in restaurants and other food service establishments
(Drobniewski, 1993).
Outbreaks involving B. cereus are nothing new. A high presence of B. cereus does not
necessarily always cause illness (Johnson, 1984). At least 230 outbreaks of the diarrheal type
gastroenteritis have been reported worldwide from 1950 to 1976, and at least 170 outbreaks of
the emetic type have been reported from 1971 to 1990 (Shinagawa, 1990). Between 1993 and
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1998 in the Netherlands, 12% of foodborne outbreaks were caused by B. cereus (Stenfors
Arnesen et al., 2008).

1.10. Conclusions and Experimental Objectives
Fermented foods, such as kombucha, are gaining traction among consumers in part due to
the functional foods movement and the desire to start living healthier lifestyles. However, there
is very little about kombucha that we know with 100% certainty, especially when it comes to
potential contamination with spore-forming foodborne pathogens and probiotic presence in the
finished product. Therefore, it is imperative that a better understanding of kombucha is
developed. Food scientists and companies want consumers of kombucha to be informed, safe,
and trusting that what is on the label is what they are getting.
This research involves two different experiments with two main experimental objectives:
(i) to determine if Bacillus cereus spores can be incorporated into a kombucha system, survive in
kombucha’s unsuitable experiment, be passed on from mother SCOBY to daughter SCOBY, or
persist in the final consumable product and (ii) to determine if known lactic acid probiotics can
grow and survive during kombucha fermentation, guaranteeing their presence in the finished
product and producing a product with the potential to provide a health benefit.
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CHAPTER 2
BACILLUS CEREUS SPORE CONTAMINATION OF KOMBUCHA SYSTEMS
BEFORE AND AFTER FERMENTATION VIA THE SCOBY, UNFERMENTED
LIQUID, OR FERMENTED LIQUID
2.1 Abstract
Kombucha is known for its high endogenous microbial load and highly acidic nature that inhibits
most extraneous microorganisms from surviving in the beverage. Although bacterial spore
contamination and survival in the culture has been documented, it is unknown whether spores
can survive in the liquid, or whether they are transmitted to daughter SCOBYs. In this study,
Bacillus cereus spores were inoculated onto SCOBY, in unfermented tea, or in fermented
kombucha, in triplicate. Survival and redistribution (to daughter SCOBY, finished, or stored
fermentate) during and after fermentation were assessed by cultural selective enrichment. The
data collected from the presence or absence of B. cereus in each sample were analyzed using best
fit logistic models (glm function) in R studio to determine any significant differences (p < 0.05)
for each inoculation treatment. Retention of spores was observed in the mother SCOBY after
direct SCOBY inoculation, and B. cereus was inconsistently transferred to the daughter SCOBY
or liquid. Only one replicate showed survival of spores in the finished kombucha after direct
liquid (post-fermentation) inoculation, and B. cereus was not detected in kombucha after
secondary fermentation or refrigerated storage. While no apparent pattern in survival was
observed, results suggest that contamination from bacterial spores may occur at any stage of
fermentation. Additional investigation should explore whether this risk is mitigated by
subsequent product storage.
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2.2 Introduction
Kombucha, a sweetened tea beverage fermented by a symbiotic colony of bacteria and
yeast (SCOBY), has seen a significant recent increase in popularity. The fermented beverage has
been produced and consumed since 220 BCE (Greenwalt et al., 2000; Jayabalan et al., 2014). It
did not enter the US commercial market until the 1990s and was only homebrewed before that
time with the starter culture (SCOBY) being passed on from friends and family members
(Greenwalt et al., 2000). Kombucha’s market entry as a packaged good coincided with the
building momentum of the functional foods movement in the late 1990s, and as a result,
kombucha and other fermented foods have become emblems of the movement due to claims such
as improved gut health, disease prevention, and high antioxidant content (Jayabalan et al., 2014;
Chakravorty, 2019). These health benefits have not been substantiated due to a lack of research
in human test subjects. Only animal models have been used, and they may not necessarily
simulate the same effects in humans (Greenwalt et al., 2000). By the 2010s, kombucha was
increasingly familiar to American consumers. However, today there is still much uncertainty
surrounding kombucha.
It is widely assumed that kombucha poses a low risk from contamination with foodborne
pathogens because it is highly acidic, has high microbial competition from yeast and bacteria
species from the SCOBY, and contains ethanol and other chemical components, deterring
harmful organism growth (Greenwalt et al., 1998; Jayabalan et al., 2014; Bhattacharya, 2018;
Battikh et al., 2013; Deghrigne et al., 2013; Četojević-Simin et al., 2012; Sreeramulu et al., 2001;
Bauer et al., n.d.) Considered a high acid food by the food industry, kombucha’s final pH of ~2.5
often limits the ability of many spoilage organisms to grow because most of them cannot grow
below a pH of 4.0 (Greenwalt et al., 2000). However, there are no studies ensuring kombucha is
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100% safe from contaminants in its final product form. The available research that has been done
on kombucha mostly focuses on its composition and/or potential health benefits. This includes
the antimicrobial activity of kombucha, regardless of green or black tea origin, but these studies
only focus on Gram-positive and Gram-negative vegetative cells in the final product after
fermentation (Greenwalt et al., 1998; Bhattacharya, 2016). Bacterial spores, in contrast, are
hardier than vegetative microorganisms and are able to survive in harsh conditions. There has
been a documented case of twenty people contracting cutaneous anthrax after applying a
kombucha SCOBY to the skin as a painkiller (Sadjadi, 1998; Smolinske, 2005). Bacillus
anthracis was identified as the culprit, and seeing as it is a spore-former, it was concluded that
Bacillus spores are capable of surviving in kombucha SCOBYs. Knowing this, it is possible that
spore-contaminated SCOBYs could potentially disseminate the spores into the kombucha liquid,
presenting a food safety hazard for kombucha consumers.
Bacillus cereus is a Gram-positive mesophilic spore-former capable of causing diarrheal
and emetic foodborne illnesses in those that consume it or its toxins (Granum & Lindbäck, 2012;
Batt, 2014). Although these illnesses do not usually warrant a hospital visit or cause fatality, B.
cereus is considered one of the two most important food spoilage and food poisoning sporeformers (Russell, 1991). Its spores are heat- and acid-stable, making it conceivable that they may
survive in kombucha’s harsh environment and end up in the final product (Notermans & Batt,
1998). One report describes the minimum pH for the growth of B. cereus as being 4.35, yet this
only describes vegetative cells and not endospores (Notermans & Batt, 1998). However, the
growth of B. cereus is not the only concern. The presence and survival of endospores in a
product, which is inevitably at a pH lower than 4.35, is also of great concern. B. cereus spores
could germination in the human GI tract and thus threaten a foodborne outbreak, putting public
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health at risk. B. cereus spores are also known to be more hydrophobic than any other Bacillus
spp. spores, making them capable of adhering to various surface types. This makes them less
susceptible to cleaning practices and disinfection, and as a result, there is a greater chance of
spores remaining on equipment surfaces, potentially contaminating foods like kombucha
(Granum & Lindbäck, 2012).
There are few published studies that assess survival of foodborne pathogens introduced to
the substrate (sweetened tea) before kombucha fermentation. Research on kombucha’s
antimicrobial abilities against pathogenic Gram-positive and Gram-negative microorganisms has
been conducted by inoculating the fully fermented liquid (Jayabalan et al., 2014). Realistically,
kombucha could be contaminated at any stage of production, and contaminants could be
introduced, either via the SCOBY, the broth, etc. A better understanding of contamination
dynamics could aid in increasing the safety of this product, such as producing more effective
HACCP plans and proactive safety measures in brewing facilities, and providing guidance for
home brewers who do not follow established food safety and sanitation plans.
This research involved examining the different routes of contamination in a kombucha
system (i.e., the SCOBY, the substrate, and the finished product) before, during, and after
fermentation. B. cereus spores were inoculated in three different kombucha systems three
different ways before and after fermentation. There were four main objectives throughout the
study, which were to determine: (i) if B. cereus spores could be more readily incorporated into
kombucha systems through the SCOBY, unfermented liquid, or fermented liquid, (ii) if B. cereus
spores could survive in kombucha’s hostile environment during and/or after fermentation, (iii) if
B. cereus spores be passed on from mother SCOBY/liquid to daughter SCOBY, and (iv) if B.
cereus spores could survive and be found in the final “consumable” product.
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2.3 Methods and Materials
2.3.1 SCOBY Preparation
Kombucha SCOBYs from three different sources (IBIV Kombucha, Chesapeake, VA),
designated throughout this chapter as A, B, and C, were grown until a biomass of 225+ grams
was reached. This was accomplished by transferring the SCOBYs from a container of finished
kombucha to a container of freshly brewed, acidified sweetened black tea every 14 days to
increase the biomass. For each container, (inoculated with one SCOBY), 1000 mL of deionized
water was boiled, and four bags of Lipton (Hoboken, NJ) black tea were brewed for 10 minutes.
The tea was cooled in an ice bath until approximately ambient temperature (~20°C) was reached.
The tea bags were removed, and the tea was combined with 100 grams of Domino’s (Yonkers,
NY) pure white cane sugar and 5% (vol/vol) of the liquid from the previous kombucha batch
(produced with the same SCOBY) was added for acidification. Once thoroughly mixed until the
sugar dissolved, the SCOBY was added to the container which was then covered with a clean
(sterile) cheesecloth and placed in a bacteriostatic incubator set to 25°C. pH was taken using the
Thermo Scientific (Waltham, MA) Orion Star A111 pH meter at the start of the fermentation
cycle, every three days thereafter, and at the end of the fermentation cycle (pH of ≤3.0). The pH
meter was calibrated before every grouping of pH reading samples with an accuracy of ≥ 95%
every time. The approximate starting pH of each fermentation cycle was 3.4, and the
approximate ending pH was 2.5. Once a SCOBY accumulated the appropriate amount of
biomass, it was covered with the container lid and placed in the refrigerator until later use.
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2.3.2 Spore Suspension
Bacillus cereus ATCC 14579 was obtained from the American Type Culture Collection
(Manassas, VA). Spore suspension preparation procedure was adapted from Sawai et al. (1995).
A 0.5 mL portion of tryptone soy broth (TSB) (Difco, Spark, MD) culture inoculated with B.
cereus (incubated at 32°C for 24 hours) was pipetted into 100 mL of a sporulation medium,
which consisted of 5 g beef extract (Oxoid, Basingstoke, England), 1 g bacto peptone (Difco,
Spark, MD), 0.5 g NaCl (Fisher Scientific, Waltham, MA), 0.05 g MnSO4 (MP Biomedicals,
Solon, OH), and 100 mL of neutral deionized water. The sporulation medium was autoclaved
before B. cereus inoculation. Inoculated sporulation medium was incubated in 100 mL aliquots
at 37°C for seven days. The sporulation medium was centrifuged in an Eppendorf (Hauppauge,
NY) Centrifuge 5810 R. The spores were washed three times with a sterile 0.9% saline solution
by centrifugation at 12,857 x g at 20°C then resuspended in saline. The final spore suspensions
were stored at 4°C until use. Spore suspension concentrations were confirmed using a Neubauer
improved hemocytometer (Hausser Scientific, Horsham, PA) and compound light microscope,
according to established methods (Counting Cells in a Hemocytometer, n.d.). A working stock
was created by diluting the original spore solution in sterile 0.9% saline as appropriate to achieve
~7.0 log spores/mL.

2.3.3 SCOBY Inoculation
A schematic representation of inoculation and analysis workflow is shown in Figure 2.2.
Pieces of SCOBY, weighing 25 g each, were cut from each SCOBY system using a kitchen knife
in replicates of three. Each 25 g SCOBY piece was placed in a clean, labeled 24 oz mason jar
(Ball, Broomfield, CO) and inoculated with 1,000 B. cereus spores. Jars were sealed and
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incubated overnight (18 hours) at ambient temperature. The following day black tea was
prepared by brewing four Lipton black tea bags per jar in 600 mL of boiling water for 10
minutes. Once cooled to room temperature in an ice bath, the tea was acidified to a pH of 4.0
with kombucha produced by the appropriate SCOBY. About 50 grams of white sugar was added
to the 600 mL of tea as a carbohydrate source for the SCOBY. The acidified sweet tea was then
added to each jar containing inoculated SCOBY, covered with cheesecloth, and put in a 25°C
incubator to ferment. pH was taken every two days until a pH of ≤ 3.0 was reached, indicating
fermentation was complete.
Once fermentation was completed, the mother and daughter SCOBYs were removed,
separated from each other, and weighed. The mother SCOBY was enriched in tryptone soy
polymyxin (TSP) broth (Difco, Sparks, MD and HiMedia, Lincoln University, PA) at a 1:9 ratio
of SCOBY:enrichment broth, incubated under conditions detailed in Table 2.1, and blended in a
Waring (Stamford, CT) 700S blender for one minute (Post, n.d.). The daughter SCOBY was cut
approximately in half using a sterile scalpel (Cynamed, Lorton, VA). One half was enriched in
TSP broth at a 1:9 ratio of SCOBY:enrichment broth and blended as previously described. The
other was kept under refrigeration for further analyses as needed. Aliquots of fermented
kombucha liquid were enriched as well. Remaining kombucha liquid was split into two. Half of
the fermented liquid was refrigerated at 4°C to simulate storage; the other half was subjected to
secondary fermentation by the addition of 20% (vol/vol) of Hannaford (Scarborough, ME) 100%
apple juice and incubated according to Table 2.1. Lastly, samples of fermented kombucha liquid
were directly spread plated in duplicate onto mannitol yolk polymyxin (MYP) agar (HiMedia,
Lincoln University, PA). The plates were incubated according to Table 2.1 to allow for any
bacterial colony formation.
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The following day all enrichments (mother SCOBY, daughter SCOBY, and fermented
liquid) were spread plated onto MYP agar in duplicate and incubated consistent with conditions
detailed in Table 2.1. After 18 hours of incubation, all plates were checked for growth of
colonies characteristic of B. cereus and results recorded (MYP Agar Base Technical Data sheet,
2015). If the enriched daughter SCOBY was positive for B. cereus (Figure 2.1), the reserved
daughter SCOBY half was used in the next brewing batch with all fractions analyzed as
described here to check for the presence or absence of B. cereus.

Figure 2.1. Mannitol Yolk Polymyxin (MYP) agar plates comparing negative and positive
growth for B. cereus.
The image on the left shows confluent growth, but the media color has changed to from pale pink
to a bright yellow, indicating this bacterial growth is not B. cereus. The image on the right shows
confluent growth, opaque zones around the colonies, and a media color change from pale pink to
hot pink, indicating the presence of B. cereus.

2.3.4 Liquid Inoculation
Black tea was prepared and acidified as previously described. The acidified sweet tea was
then divided among clean and labeled jars and inoculated with 24,000 B. cereus spores. At this
point, inoculated tea was plated onto MYP in duplicate and incubated according to Table 2.1.
Pieces of SCOBY, weighing 25 grams each, were cut from each SCOBY system in replicates of
three, totaling 9 pieces of SCOBY across all systems. The SCOBYs were added to the inoculated
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tea, covered with cheesecloth, and put in a 25°C incubator to ferment. pH was taken every two
days until a pH of ≤ 3.0 was reached, indicating fermentation was complete.
Table 2.1. Treatments performed after fermentation and their respective temperature and
duration throughout all B. cereus inoculations
Treatment

Temperature (°C)

Duration (hours)

Inoculations Performed In

Enrichments

37

24

SCOBY, Liquid, Finished
Product

MYP Plating

32

18

SCOBY, Liquid, Finished
Product

Secondary
Fermentation

25

48

SCOBY, Liquid, Finished
Product

Refrigeration

4

1 week

Finished Product

After fermentation, the mother and daughter SCOBYs were removed from the jars. The
mother SCOBY was disposed of while the daughter SCOBY was weighed and cut in half. Half
of the daughter SCOBY was stored for additional analyses, and the other half was enriched in
TSP broth as previously described. Simultaneously, a portion (25 mL) of the fermented liquid
was enriched in TSP broth. The remaining liquid was split into two. Half of the fermented liquid
was refrigerated at 4°C to simulate storage; the other half was subjected to secondary
fermentation by the addition of 20% (vol/vol) of Hannaford (Scarborough, ME) 100% apple
juice and incubated according to Table 2.1. Lastly, samples of fermented kombucha liquid were
directly spread plated in duplicate onto MYP agar. The plates were incubated according to Table
2.1 to allow for any bacterial colony formation.
The following day all enrichments (daughter SCOBY and fermented liquid) were plated
onto MYP agar in duplicate and incubated consistent with conditions detailed in Table 2.1. If the
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enriched fermented liquid plates were positive for B. cereus, the secondary fermentate was plated
onto MYP agar in duplicate and subsequently assessed for the presence of B. cereus after 18
hours. Additionally, if the enriched fermented liquid plates were positive for B. cereus, the
fermented liquid stored under refrigeration was enriched with TSP broth after one week and
plated onto MYP agar in duplicate to see if viable B. cereus spores were still present in the liquid
after storage. If the enriched daughter SCOBY plates were positive for B. cereus, the saved
daughter SCOBY half was used in the next brewing batch and went through the process again to
check for the presence or absence of B. cereus.

2.3.5 Finished Product Inoculation
Black tea was prepared and acidified as previously described. The acidified sweet tea and
pieces of SCOBY, weighing 25 g each, were simultaneously added to clean and labeled jars,
covered with cheesecloth, and put in a 25°C incubator to ferment. pH was taken every two days
until a pH of 3.0 was reached, indicating fermentation was complete.
Once fermentation was complete, the mother and daughter SCOBYs were removed from
the jars. The mother SCOBY was disposed of while the daughter SCOBY was weighed and
stored at 4ºC for additional analyses. The fermented liquid was then inoculated with 24,000 B.
cereus spores per jar. Samples of inoculated tea were plated onto MYP in duplicate and placed in
a 32°C incubator for 18 hours. The remaining liquid was split into two. Half of the fermented
liquid was refrigerated at 4°C to simulate storage; the other half was subjected to secondary
fermentation by the addition of 20% (vol/vol) of Hannaford (Scarborough, ME) 100% apple
juice and incubated in conditions consistent with Table 2.1. After 48 hours, a portion (25 mL) of
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the secondary fermentate was enriched in TSP broth and incubated according to Table 2.1. The
remaining secondary fermentate was stored at 4ºC for additional analyses.
The following day the secondary fermentate enrichments were plated onto MYP agar in
duplicate and incubated according to Table 2.1. If the enriched secondary fermentate plates were
positive for B. cereus, the secondary fermentate stored under refrigeration was enriched with
TSP broth after one week of storage week and plated onto MYP agar in duplicate to see if viable
B. cereus spores were still present in the liquid after storage. The half of the fermented liquid that
did not go through secondary fermentation was refrigerated consistent with conditions detailed in
Table 2.1. A portion (25 mL) of the fermented liquid was then enriched in TSP broth and
incubated according to Table 2.1. The next day samples of this enrichment were plated onto
MYP in duplicate and incubated according to Table 2.1. The plates were checked and recorded
for B. cereus growth, determining whether the spores could survive storage without having gone
through secondary fermentation.

2.3.6 Statistical Analysis
Data were analyzed in R and R studio Version 1.4.1103 (Boston, MA) using multiway
ANOVA and the best fit logistic regression models (glm function) to generate a worldwide
model to recognize the interactions defined by the inoculation methods and by the portion of the
kombucha system inoculated. Tukey’s post hoc test was then used as a pairwise comparison to
identify any significant differences (p˂0.05) among the interactions.
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Figure 2.2. Overall inoculation methods of B. cereus spores into the SCOBY, unfermented
tea (liquid), or fermented tea (finished product)
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2.4 Results and Discussion
Table 2.2 displays the presence and absence results of the SCOBY inoculations among
the three tested kombucha systems. All enrichments had a detection limit of 1 CFU/25 mL or 1
CFU/25 grams. For the direct liquid samples, which were not enriched, a negative result
indicated <10 CFU/mL. All but one mother SCOBYs were positive for presence of B. cereus, as
expected. Kombucha system A was negative for the presence of B. cereus in the enriched
daughter SCOBY, but two of three enriched liquid samples were positive for presence of B.
cereus. Even though the replicates were positive, there was a decrease of B. cereus from the
amount initially inoculated. Consequently, those two replicate jars went through secondary
fermentation and were plated onto MYP agar. As indicated by Table 2.2, liquid from secondary
fermentation tested negative, suggesting that subsequent fermentation was sufficient to inactivate
the spores.
Table 2.2. Presence or absence of B. cereus in inoculated kombucha cultures and
fermentate at various stages of preparation [SCOBY inoculation of B. cereus]
Direct Liquid Enriched
Secondary
[after
Liquid3 Fermentation3
fermentation]4

Total2

Kombucha
System

Enriched
Mother
SCOBY3

Enriched
Daughter
SCOBY3

A

2/3

0/3

0/3

2/3

0/2

4/12

B

3/3

1/3

0/3

1/3

0/1

5/12

C

3/3

0/3

0/3

0/3

N/A1

3/12

1

: No enriched liquid samples were positive, so there was no need to check secondary
fermentation samples because it is already known there is no B. cereus present.
2
: Excludes secondary fermentation column from total count
3
: Positive enrichment means at least 1 CFU/25 mL
4
: Negative liquid means <10 CFU/mL
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Kombucha system B had one replicate out of three return positive for both the enriched
liquid samples and the enriched daughter SCOBY samples. The secondary fermentation of the
one positive enriched liquid replicate was hence plated and returned negative for the presence of
B. cereus. The saved daughter SCOBY half of the one positive enriched daughter SCOBY
replicate was used to rebrew a new batch of kombucha under the same conditions as the mother
SCOBY was brewed in (Section 2.3.3). The enriched daughter SCOBY (now acting as the
“mother SCOBY” in this scenario) was positive, as expected, but the enriched [grand]daughter
SCOBY, direct liquid, and enriched liquid samples were all negative, meaning the transfer and
presence of B. cereus ended here. This kombucha system showed a 33% transfer rate from
mother to daughter SCOBY and a 33% transfer rate from SCOBY to liquid, however the liquid
was only positive for B. cereus when enriched and not when directly plated onto MYP without
enrichment, indicating a low level of survival. Presence of B. cereus was no longer detected once
secondary fermentation had occurred.
All samples taken for kombucha system C, besides the enriched mother SCOBY, were
negative for the presence of B. cereus. No enriched liquid samples were positive, indicating the
absence of B. cereus. Because there was no B. cereus detected in the enriched liquid samples,
secondary fermentation was not performed.
Among all three kombucha systems, the inoculated mother SCOBY samples were almost
always positive, as expected, but the respective daughter SCOBY and enriched liquid samples
were not always positive. This implies that the B. cereus spores were able to be incorporated into
the SCOBY, and the transfer of spores from mother SCOBY to daughter SCOBY or from mother
SCOBY to the liquid was sporadic. Upon contamination, this tells us pathogenic spore-formers
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are capable of being taken up by the SCOBY but have a low chance of being passed on either to
the daughter SCOBY or liquid.

Table 2.3 displays the presence and absence results of B. cereus resulting from
inoculation of tea before fermentation. There were no positives for any of the replicates of all
three kombucha systems for the direct liquid samples taken at inoculation and samples taken
immediately after fermentation. These samples were not enriched with the TSP enrichment
broth. Theoretically, there should be about 4 spores per plating of direct liquid at inoculation and
after fermentation based on the amount of spores inoculated into the broth (24,000 spores/600
mL), but samples were taken from the top inch of the broth which may have been void of spores,
regardless of stirring beforehand. However, two of the three systems displayed positive replicates
later on in testing. This is because there was not enough detectable B. cereus to warrant presence
without enrichment when taken at inoculation and right after fermentation.
Table 2.3. Presence or absence of B. cereus in inoculated kombucha fermentate and
associated cultures at various stages of preparation [Liquid inoculation of B. cereus]
Kombucha
System

Liquid at
Inoculation

Direct Liquid
[after
fermentation]

Enriched
Daughter
SCOBY

Enriched
Liquid

Secondary
Fermentation

A2

0/3

0/3

0/3

1/3

0/1

B3

0/3

0/3

1/3

0/3

N/A1

C4

0/3

0/3

0/3

0/3

N/A1

1

: No enriched liquid samples were positive, so there was no need to check secondary
fermentation samples because it is already known there is no B. cereus present.
2
: Average pH at the end of fermentation for kombucha system A was 3.01
3
: Average pH at the end of fermentation for kombucha system B was 2.99
4
: Average pH at the end of fermentation for kombucha system C was 3.00
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Kombucha system A revealed only one positive replicate for enriched liquid among the
entirety of the samples tested. Consequently, the secondary fermentation of this positive replicate
was plated onto MYP agar and returned negative for the presence of B. cereus. Kombucha
system B also exhibited only one positive replicate for the enriched daughter SCOBY among the
entirety of the samples tested. This positive result warranted the second brewing of daughter
SCOBY, using the same conditions as the mother SCOBY was brewed in. However, because no
enriched liquid plates were positive, secondary fermentation was not necessary to carry out
because it was already determined there was no B. cereus present in the liquid. The second
brewing results of the daughter SCOBY indicated the absence of B. cereus everywhere except in
the original daughter SCOBY which remained positive for B. cereus, as established from before.
Much like the SCOBY inoculation, all samples taken from kombucha system C were negative
for the presence of B. cereus. No enriched liquid samples were positive, indicating the absence of
B. cereus in the liquid, so plating the secondary fermentation samples to check for the presence
of B. cereus was unnecessary.
Survival of spores inoculated into the liquid was observed in only one out of nine
replicates. Transfer of spores from the liquid to the culture was not evident except for one
daughter SCOBY replicate in the Kombucha system B and therefore displays the transfer of
spores from contaminated tea (pre-fermentation) is less likely than transfer from contaminated
SCOBY.
Table 2.4 displays the presence and absence results of B. cereus inoculation directly into
finished product, or fermented liquid, among the three tested kombucha systems. No positives
were detected for any of the replicates of all three systems for the liquid samples taken after
fermentation when inoculated with B. cereus spores. These samples were not enriched with the
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TSP enrichment broth. Theoretically, there should be about 4 spores per plating of direct liquid
at inoculation and after fermentation based on the amount of spores inoculated into the broth
(24,000 spores/600 mL), but samples were taken from the top inch of the broth which may have
been void of spores, regardless of stirring beforehand. Additionally, there was mostly likely not
enough detectable B. cereus to warrant presence without enrichment. As a result, enrichment of
the one week wait [primary fermentation] samples and the secondary fermentation samples were
necessary to lower the detection limit and confirm the presence or absence of B. cereus. As it
turned out, two of the nine samples analyzed displayed positive results after one week of storage
at 4°C.
Table 2.4. Presence or absence of B. cereus in inoculated kombucha after fermentation and
subsequent refrigerated storage [Finished product inoculation of B. cereus]
Kombucha
System

Direct Liquid
[after fermentation]

Secondary
Fermentation

0/3

One week wait
[primary
fermentation]
1/3

A
B

0/3

1/3

0/3

C

0/3

0/3

0/3

0/3

In Kombucha systems A and B, one out of the three replicates was positive after primary
fermentation and stored in the refrigerator at 4°C for one week. However, there was no B. cereus
present in the samples taken from the post-fermentation inoculated liquid or secondary
fermentation in both systems. The secondary fermented liquid was not tested after one week
storage in the refrigerator because the absence of B. cereus right after the conclusion of
secondary fermentation implies it would still be absent after storage. Kombucha system C was
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negative for all samples tested for B. cereus presence including post-fermentation inoculation,
one week storage, and secondary fermentation.
While rare, survival of post-fermentation spore contaminants during storage is possible.
Table 2.4 illustrates that contamination during any part of the brewing process could pose a risk
to consumers, as even extended storage does not completely inactivate spores.
Overall, samples positive for the presence of B. cereus were sporadic. Positive replicates
were only confirmed after the respective samples were enriched for 24 hours. This indicates
there is only a small amount of B. cereus present (≥1 CFU/25 mL or ≥1 CFU/25 g), if any at all,
and it needs enrichment in order to produce growth. If ingested, the number of spores may be too
little to cause illness since the estimated infectious dose is at least ˃10 5 spores or vegetative cells
(Batt, 2014). Although, doses as low as 103 B. cereus CFU/g of food have been found in foods
causing disease (Stenfors Arnesen, Fagerlund, & Granum, 2008). In addition, all secondary
fermentation samples were negative regardless of inoculation method or interaction. This
signifies that if the spores can survive the initial fermentation, they are most likely not able to
survive the secondary fermentation. No significant differences (p≤0.05) were found in likelihood
of spore recovery between the inoculation methods or in the presence of B. cereus in a specific
portion (daughter SCOBY or liquid) of the product. However, data collected in this study reveals
some kombucha systems (kombucha system C) may be more robust and less likely to become
contaminated than others (kombucha systems A and B). Therefore, antibacterial differences
between kombucha systems should be further explored to determine which systems are more
likely to prevent contamination of spore-formers and should be used for brewing.
Temperature abuse may play a role in the germination and growth of B. cereus
endospores in a kombucha system. B. cereus’s optimum temperature range overlaps with the
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microorganisms responsible for kombucha fermentation (mainly acetic acid bacteria) because
they are both mesophilic organisms. However, B. cereus’s overall growth temperature range is
more extensive (10ºC-50ºC) than acetic acid bacteria (20ºC-37ºC) and thus has the ability to
grow at higher and lower temperatures when the working bacteria has slowed or died off also
minimizing microbial competition (Lu, Lee, & Chen, 1999; Bacillus cereus—BfR, n.d.; “How
Temperature Affects Kombucha”, 2019). The reduction of competitive microbiota and poorly
temperature-controlled conditions support the germination of the spores and the growth of
vegetative cells (Bacillus cereus—BfR, n.d.).

2.5 Conclusions
The portion of the kombucha system inoculated did not significantly influence the
likelihood of survival of B. cereus within the kombucha system. Equal survival was observed in
the daughter SCOBY and the liquid regardless of inoculation method or kombucha system used.
Results show the spread of B. cereus is sporadic but possible, so hygienic handling of kombucha
cultures and raw materials throughout the entire production process is crucial to prevent uptake
of pathogenic organisms. Additionally, there was no survival after 1-week storage or secondary
fermentation, indicating that implementation of a holding step may mitigate potential food safety
threats.
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CHAPTER 3
SURVIVAL OF PROBIOTIC LACTOBACILLUS SP. DURING FERMENTATION TO
PRODUCE A PROBIOTIC KOMBUCHA BEVERAGE
3.1 Abstract
Kombucha is noted for its taste, sensorial qualities, and supposed health benefits. The beverage
is perceived to automatically contain probiotics, but not all live cultures contain probiotics as
many consumers believe. In this study, the survivability of six probiotic Lactobacillus sp. was
established in MRS or sweetened tea at recommended temperature (30ºC or 37ºC) or 25ºC to
create bacterial growth curve models for predicting probiotic populations under certain
conditions. Once it was determined the probiotics could grow in sweetened tea at 25ºC,
kombucha fermentation was carried out with each probiotic until a pH of 3.0 was reached, and
the probiotic populations were documented throughout fermentation and storage. Model
comparison was performed using multiway ANOVA in R studio to decipher significant
differences (p˂0.05) between treatments and between probiotics. Temperature and medium had
an effect on the probiotic growth rates, and results showed the probiotics survived better in
sweetened tea at 25ºC than in sweetened tea at recommended temperature. Differences in pH
indicated the probiotics were unable to acidify the tea pre-fermentation. Fermentation lasted on
average 8.3 days, and probiotic populations revealed an acidic threshold around day 6. GABA
and other biogenic amines were not detected in the lactic acid bacteria inoculated kombucha
samples at a detection limit of 1 μmol. It was concluded that probiotic Lactobacillus sp. are not
well suited for a probiotic kombucha beverage but out of the tested probiotics, L. brevis and L.
fermentum are the best candidates of the species tested in this study.
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3.2 Introduction
Tea is the most consumed beverage in the world after water, with green and black tea
being the most popular tea varieties, so it is no surprise that kombucha has become increasingly
popular over the past few decades for its taste, sensory profile, and potential health benefits
(Chakravorty et al., 2019). Kombucha is a tea beverage that goes through a double fermentation
process using a symbiotic colony of bacteria and yeasts (SCOBY) to create a slightly carbonated
drink with a tangy vinegar flavor (Kombucha | Description, History, & Nutrition, n.d.). It is
usually consumed as a health beverage because of its functional features and is often an
alternative to traditional soft drinks. As a result, kombucha has become one of the most popular
low-alcoholic fermented beverages in the world (Baschali, 2017). In the US, it was solely
brewed at home using a tea fungus passed from home to home until the commercialization of the
product in 1995 when GT Dave started his brand “GT’s Kombucha” (Dufresne & Farnworth,
2000; Bauer et al., n.d.; Kombucha Brewers International, n.d.). It then surfaced as a health
product because of the public push towards a healthier lifestyle at the time and greater awareness
of probiotics and the health benefits of fermented foods (Kombucha | Description, History, &
Nutrition, n.d.). Kombucha has since become the fastest-growing product in the functional
beverage sector (Bauer et al., n.d.; Kombucha Brewers International, n.d.). The fermented
beverage can now be found commercially around the globe in larger chain stores and not just in
health or natural foods stores although many consumers still continue to practice kombucha
fermentation at home.
Most of kombucha’s rise in popularity is not only due to its taste and sensorial qualities
but also its supposed health benefits, such as having antioxidant, antidiabetic, hepatoprotective,
antimicrobial, anti-inflammatory, and anticancer capabilities as well as being able to lower
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stress, blood pressure, and cholesterol (Chakravorty et al., 2019). These health effects may be
due to the known benefits of tea itself in addition to the products formed in the beverage during
fermentation, which include glucuronic acid, acetic acid, polyphenols, and B-complex vitamins
(Baschali, 2017). To date, here have been no kombucha consumption studies using human
models to confirm these health benefits.
Kombucha is likewise promoted for its supposed probiotic presence. Many consumers
think that all live cultures offer probiotic benefits. This is not true. Although unpasteurized
kombucha typically contains high levels of live organisms, these do not comprise proven
probiotic species, or organisms closely related to probiotics. Probiotics are generally defined as
“live microbial food ingredients that, when ingested in sufficient quantities, have health benefits
on the consumers by acting either directly or indirectly via interactions with the gut microbiota”
(Tur & Bibiloni, 2016; Asaithambi, Singh, & Singha, 2021; Bauer et al., n.d.; Siró, Kápolna,
Kápolna, & Lugasi, 2008). Upon consumption, probiotics have the ability to restore, balance, or
maintain the gut microbial population, function, and composition (Asaithambi, Singh, & Singha,
2021). Their major health benefits include lactose intolerance alleviation, the reduction of
digestive infections via immune stimulation, and the reduction of precancerous gastrointestinal
lesions (Tur & Bibiloni, 2016).
Probiotic microorganisms mainly consist of Lactobacillus and Bifidobacterium species,
which are also normal components of the human intestinal microbiota. They are the most studied
and widely employed bacteria within the probiotic classification and have a long tradition of safe
application within the food industry (Siró, Kápolna, Kápolna, & Lugasi, 2008). Even though
these species can sometimes be found in the intestinal microbiota, added probiotics may change
the microbiota, but they do not become a permanent part of the microbiota when consumed,
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passing through the intestinal tract (Tur & Bibiloni, 2016). Thus, regular consumption of 100
grams or more of probiotics are recommended to produce palpable health effects (Tur &
Bibiloni, 2016; Asaithambi, Singh, & Singha, 2021). However, these organisms are only minor
parts, if present at all, in the kombucha biome.
Kombucha microbiota varies from batch to batch depending on the SCOBY’s microbial
community, but there are a few species of bacteria and yeasts that one can find in almost every
batch of kombucha. The most predominant species most often found in kombucha are
Acetobacter and Gluconobacter bacteria and Brettanomyces, Zygosaccharomyces,
Saccharomyces, and Candida yeasts (May, 2019; Greenwalt, Steinkraus, & Ledford, 2000).
Smaller traces of Lactobacillus, Lactococcus, Pichia, Schizosaccharomyces, and Kloeckera can
be found in kombucha, but they are not always present (Chakravorty et al., 2019; Dufresne &
Farnworth, 2000; Reva, 2015; Ivanišová, 2020). Since probiotics are largely Lactobacillus and
Bifidobacterium species, they may be naturally-occurring in the kombucha as part of the lactic
acid bacteria population, but usually comprise a significant minority of the composition. Thus, it
cannot be assumed these “naturally occurring” probiotics are present, or if they are present, it
cannot be assumed they are present in high enough amounts to be effective. Therefore, it is
recommended that exogenous probiotics be added to the beverage in order to proclaim it a
probiotic beverage. The question then becomes: When should the probiotic be added to the
beverage? Before or after fermentation? Additionally, which probiotic is most likely to survive in
kombucha’s environment and deliver benefits to the consumer? More research guaranteeing
probiotic efficacy in kombucha is needed, questioning which probiotic should be added, when
said probiotic should be added, and whether kombucha can deliver the said probiotic’s effects.
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In order to attain the full effects of probiotics, they must be maintained in the food
product at sufficient levels from processing until consumption. The minimal level of probiotics
required to be in the final processed product in order to assert the health benefits at the time of
consumption is at least 106 CFU/g (Asaithambi, Singh, & Singha, 2021; Corbo et al., 2014).
Successful probiotics in foods must be able to survive and be adsorbed by the gastrointestinal
tract. The food matrix in which the probiotics are incorporated also plays a significant role in cell
survival in the food (Asaithambi, Singh, & Singha, 2021). Temperature and the probiotic strain’s
resistance to withstand various food processing procedures are the two most important
parameters when selecting the appropriate probiotic strains and processing conditions for a
probiotic food (Asaithambi, Singh, & Singha, 2021).
Although kombucha may not be a suitable environment for these [Lactobacillus]
probiotics, there are ways that probiotics can be beneficial even if they’re not viable such as
management of gastrointestinal disorders, protection against enteropathogens, maintenance of
intestinal barrier integrity, and the presence of their metabolites, like gamma-aminobutyric acid
(GABA), if they are produced in high enough quantities before the cells die (Piqué, Berlanga, &
Miñana-Galbis, 2019). Gamma-aminobutyric acid (GABA) is a non-protein amino acid produced
by various plants, animals, and microorganism through glutamate decarboxylase (GAD) activity
(Diez-Gutiérrez, 2020; Corbo et al., 2014). It is known to have a substantial role in behavior,
cognition, disease prevention, gut microbiota function, and the body’s response to stress (DiezGutiérrez, 2020; Cui, Miao, Niyaphorn, & Qu, 2020). When present in adequate amounts in
fermented foods, the health benefits of consuming this amino acid include gut modulation,
neurostimulation, and cardioprotection (Diez-Gutiérrez, 2020). A large number of LAB species
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are capable of producing GABA, but Lactobacillus brevis and Lactobacillus plantarum are noted
as two of the best producers of GABA (Cui, Miao, Niyaphorn, & Qu, 2020).
This research sought to assess the feasibility of the production of a kombucha beverage
with health-promoting characteristics derived from the inclusion of LAB probiotics. Specific
objectives included: (i) determining the suitability of sweetened tea as a growth medium for
selected probiotic LAB species (ii) determining the survivability of LAB during active
kombucha fermentation and storage (iii) determining the differences in GABA production by
LAB probiotics under ideal conditions compared in a kombucha system.

3.3 Methods and Materials
3.3.1 SCOBY Preparation
Only SCOBY from one system (IBIV Kombucha, Chesapeake, VA) was used throughout
this study. The system was grown until a biomass of 900+ grams was reached. This was
accomplished by transferring the SCOBY from a container of finished kombucha to a container
of freshly brewed, acidified sweetened black tea every 14 days to increase the biomass. For each
rebrewing cycle, 1000 mL of deionized water was boiled, and four bags of Lipton (Hoboken, NJ)
black tea were brewed for 10 minutes. The tea was cooled in an ice bath until approximately
ambient temperature (~20°C) was reached. The tea bags were removed, and the tea was
combined with 100 grams of Domino’s (Yonkers, NY) pure white cane sugar and 5% (vol/vol)
of the liquid from the previous kombucha batch (produced with the same SCOBY) was added for
acidification. Once thoroughly mixed until the sugar dissolved, the SCOBY was added to the
container which was then covered with a clean (sterile) cheesecloth and placed on a clean,
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isolated windowsill at approximately ambient temperature (~25°C). pH was taken using the
Thermo Scientific (Waltham, MA) Orion Star A111 pH meter at the start of the fermentation
cycle and at the end of the fermentation cycle (pH of ≤3.0). The pH meter was calibrated before
every grouping of pH reading samples with an accuracy of ≥95%. The approximate starting pH
of each fermentation cycle was 3.1, and the approximate end pH was 2.5. Once the SCOBY
accumulated the appropriate amount of biomass, it was covered with the container lid and placed
in the refrigerator until later use.

3.3.2 LAB Preparation
Six different Lactobacillus species, categorized as probiotic lactic acid bacteria (LAB),
all sourced from the American Type Culture Collection (Manassas, VA) were used:
Lactobacillus plantarum ATCC 8014 , Lactobacillus bulgaricus ATCC 11842, Lactobacillus
brevis ATCC 14869 strain Bb14, Lactobacillus fermentum ATCC 9338, Lactobacillus casei
ATCC 393, and Lactobacillus sakei ATCC 15521. A loopful of L. plantarum, L. bulgaricus, and
L. brevis -80°C freezer stock was each inoculated into separate deMan, Rogosa, and Sharpe
(MRS) broth tubes (Difco, Sparks, MD). The L. plantarum, L. bulgaricus, L. brevis tubes were
incubated at recommended temperature (Table 3.1) overnight. Once bacterial growth in the tubes
was visible, the tubes were vortexed for 10 seconds using the Fisher Scientific Vortex Mixer
(Waltham, MA), and each organism was streak plated onto MRS agar in duplicate for colony
isolation. The MRS plates were then placed in their respective incubators for 24-48 hours to
allow for bacterial colony formation. L. fermentum, L. casei, and L. sakei were regenerated using
Microbiologics’s KwikStik™ (Saint Cloud, MN). Following the directions in the KwikStik kit,
the bacteria were hydrated in the stick containing the bacteria and streak plated onto MRS agar in
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duplicate for colony isolation (KWIK-STIK Plus Instructions For Use, n.d.). The MRS plates
were then incubated at recommended temperature (Table 3.1) for L. fermentum, L. casei, and L.
sakei for 24-48 hours to allow for bacterial colony formation.
Table 3.1. Recommended Incubation Temperatures1 Used for Each Species of
Lactic Acid Bacteria
Probiotic

L. plantarum

Recommended Incubation
Temperature
(ºC)1
37

L. bulgaricus

37

L. brevis

30

L. fermentum

37

L. casei

37

L. sakei

37

1

Temperatures obtained from references: Lactobacillus plantarum (Orla-Jensen) Bergey
et al. | ATCC, n.d.; Lactobacillus delbrueckii subsp. Bulgaricus (Orla-Jensen) Weiss et
al. | ATCC, n.d.; Lactobacillus brevis (Orla-Jensen) Bergey et al. | ATCC, n.d.;
Lactobacillus fermentum Beijerinck | ATCC, n.d.; Lactobacillus casei (Orla-Jensen)
Hansen and Lessel | ATCC, n.d.; Lactobacillus sakei subsp. Sakei Katagiri et al. |
ATCC, n.d.

3.3.3 Sweetened Tea Preparation
Black tea was prepared by brewing four Lipton black tea bags in 600 mL of boiling
deionized water for 10 minutes. The tea was cooled in an ice bath until approximately ambient
temperature (~20°C) was reached. The tea bags were removed, and the tea was combined with
100 grams of Domino’s (Yonkers, NY) pure white cane sugar. The tea was thoroughly mixed
until the sugar was completely dissolved.
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3.3.4 LAB Growth Curves
Growth curves were created in triplicate for each LAB species in the following
medium/temperature treatments: MRS broth incubated at recommended temperature (Table 3.1),
MRS broth incubated at 25ºC, sweetened tea (prepared as described in section 3.3.3) incubated at
recommended temperature (Table 3.1), and sweetened tea incubated at 25ºC. Within each
replicate, duplicate platings were performed for each time point (n=6 tubes per
species/treatment/time). At each sampling time (every 4 hours over 24 hours), a unique tube (no
repeated sampling) of inoculated broth was diluted as appropriate in sterilized peptone water and
spread-plated in duplicate onto MRS agar, which was subsequently incubated for 48 hours at
species specific recommended temperature (Table 3.1).
The bacterial colonies were counted using plate counting techniques, and the CFU/mL
were calculated and log transformed (Perry, 2019). Remaining sample left in the 24-hour tubes
was filter sterilized using Fisher Scientific (Waltham, MA) 0.22μm sterile 13mm syringe filter
with a PVDF membrane and placed in the -80°C freezer for future chromatographic analysis.
The pH of 20-hour samples was measured and compared to the non-inoculated MRS broth to
assess LAB acidification of the medium.

3.3.5 LAB Culture Preparation for Kombucha Fermentation
Each LAB was inoculated into sterile MRS broth in triplicate. Within each replicate,
duplicate MRS broth tubes were inoculated per species (n=6 tubes per species). The culture tubes
were incubated overnight (24 hours) at the organism’s recommended optimal growth
temperature (Table 3.1). To confirm the amount of probiotic being put into each jar of tea,
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samples from the culture tubes were diluted as appropriate in peptone water and plated onto
MRS agar in duplicate and incubated at recommended temperature (Table 3.1). Each overnight
culture had a population of ~9 log CFU/mL, confirmed by spread plating.

3.3.6 Probiotic Inoculation into Tea and Survival Through Kombucha Fermentation
The probiotic LAB cultures were prepared (as described in section 3.3.5) for prefermentation inoculation into tea. Sweetened tea was prepared as previously described in section
3.3.3 and acidified to a pH of 4.0 with previously brewed kombucha produced with the same
SCOBY system. Tea, SCOBY, and LAB cultures were added to clean mason jars (Ball,
Broomfield, CO) in triplicate. Within each replicate, duplicate jars were produced to attain six
jars per species. The LAB cultures added to each jar inoculated the pre-fermented tea with a
single designated probiotic at a level of 1% of the tea by volume, representing a starting
inoculum level of approximately 9.0 log CFU/mL. The jars were then covered with cheesecloth
and incubated at 25°C.
One hour after the probiotic inoculation, samples were taken aseptically from each jar,
diluted in sterilized peptone water, plated onto MRS agar in duplicate, and incubated at
recommended temperature (Table 3.1) to assess immediate loss of viability due to inoculation
into acidified sweet tea (when compared to culture plating as described in section 3.3.5). These
bacterial counts were designated as the “Day 0” population. Kombucha sample pH and surviving
LAB population were measured daily until a pH of ≤3.0 was reached. The kombucha jars were
stirred 10 times with a sterile glass rod, and samples were taken from the top inch of liquid. The
samples were diluted in sterilized peptone water and plated onto MRS agar in duplicate. The
MRS plates were incubated for 48 hours at recommended temperature (Table 3.1) then counted
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and recorded. If there was no more growth on the MRS plates because the probiotic population
had decreased below detection limit (0 CFU/mL), plating ceased for that replicate, but pH was
still measured every day until each kombucha jar reached a pH of 3.0, at which point
fermentation was considered complete, and the SCOBY was removed. Samples of fermentate
were saved in falcon tubes in duplicate in the -80°C freezer for subsequent GC-MS analysis. If
probiotic population was still above detection limit in the fully fermented kombucha, samples of
the liquid (sans SCOBY) were stored at 4°C and plated onto MRS agar after one week.

3.3.7 Gas Chromatography-Mass Spectrometry (GC-MS) Analysis of Biogenic Amines in
Probiotic-Inoculated Kombucha
GC-MS was performed using EZ:faasttm amino acid analysis kit (PN: KG0-7166) by
Phenomenex (Torrance, CA). Sample and analytical standard preparation and analysis was
accomplished by following the directions accompanying the kit. Preparation included a solidphase extraction step where amine compounds in the sample matrix or standards were bound to a
sorbent-packed tip. Bound amino acids within samples were evaluated while allowing interfering
compounds to flow through and discarded. The amino acids on sorbent were eluted into sample
vials and derivatized with reagent at room temperature in aqueous solution. The derivatized
amino acids simultaneously migrated to the organic layer for additional partitioning from
interfering compounds. The organic layer was removed, evaporated, suspended in redissolution
solvent and injected into the GC-MS system.
Kombucha, unfermented sweetened tea, and MRS broth samples inoculated with the six
tested Lactobacillus sp. (L. plantarum, L. bulgaricus, L. brevis, L. fermentum, L. casei, L. sakei)
were tested. Analytical standards, purchased from Sigma-Aldrich Co. (St. Louis, MO) included
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gamma aminobutyric acid (GABA), putrescine, cadaverine, histamine, tyramine, spermine,
spermidine and tryptamine. Stock solutions for individual standards were prepared by dissolving
50 mg of each standard in 50 mL of deionized water.
An Agilent model 6890 gas chromatograph coupled with a 5973 mass spectrometer
(GC/MS) was used to identify and quantify individual amines in the kombucha. The GC column
was provided with the EZfaasttm kit with the dimensions of 10 M x 0.025 ID. The column
contained a proprietary separation phase of unknown thickness. A split injection mode,
maintained at 250°C, was chosen with a 2:1 split ratio to maximize sensitivity for targeted
analytes. The mass spectrometer was operated in the scan mode with a low mass of 45 and a high
mass of 450 M/z (mass/charge). The MS source was maintained at 240ºC, and the MS quad was
maintained at 180°C. The GC oven was programed and held for three minutes at an initial
temperature of 110ºC. The temperature was raised isocratically at 30ºC/minute to 320ºC where it
was held for the last five minutes of each run, for a total run time of 15 minutes. Target analytes
were identified by retention time and ion fragmentation (M/z). Biogenic amines concentrations
in kombucha samples were quantified by comparing peak areas of samples with peak areas of
analytical standards of known concentrations. An internal standard, norvaline (included in the
EZ:faasttm kit), was used to correct for differences in final volumes and derivatization
efficiencies.
The detection limit (5:1, signal:noise) for each of the eight biogenic amines tested was 1
μmol and was determined using standard dilutions of each analytical standard.
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3.3.8 Statistical Analysis
Data were analyzed in R and R studio Version 1.4.1103 (Boston, MA) using polynomial
regression models (lm function) to represent best fit of the data. Each model was chosen based
on R2 value and likeness to data points when graphed. Four models were created per probiotic to
represent each treatment (MRS broth at recommended probiotic temperature, MRS broth at
25ºC, sweet tea at recommended probiotic temperature, and sweet tea at 25ºC) for a total of 24
models. Model comparison was performed using multiway ANOVA to decipher significant
differences (p˂0.05) between treatments and between probiotics.
Multiway ANOVA was performed on the pH values taken at the 20-hour interval to
identify any significant differences (p˂0.05) among final pH values for each probiotic. Tukey’s
post hoc test was then used as a pairwise comparison to determine any specific significant
(p˂0.05) interactions.

3.4 Results and Discussion
The aim of this study was to determine if selected probiotics (L. plantarum, L.
bulgaricus, L. brevis, L. fermentum, L. casei, L. sakei) could grow in sweet tea before or during
kombucha fermentation and/or produce gamma-aminobutyric acid (GABA) or other biogenic
amines. Because kombucha is fermented at a maximum of 25ºC, we first had to assess if the
decrease in temperature from species “optimal” values would have an effect on probiotic growth,
if medium (sweetened tea) would have an effect on probiotic growth, and if the combination of
temperature and medium would have an effect on probiotic growth. This would help determine if
the probiotics would be able to survive and grow under fermentation conditions (sweetened,
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acidified tea at 25ºC). Growth in sweetened tea at recommended temperature could provide the
option of acidification of the kombucha substrate with probiotic LAB (as opposed to standard
practice of using previously fermented kombucha or acetic acid). Assuming the cultures could
grow in tea at 25ºC, indicating that viability may be possible in the finished beverage, kombucha
fermentation was carried out with the six Lactobacillus present, and kombucha’s contents were
analyzed to see if probiotics survived and if any GABA was produced.

3.4.1 Bacterial Growth Curves as Predictor Models for Probiotic Kombucha Fermentation
The bacterial growth curves generated in MRS broth at the probiotic’s recommended
temperature (visualized in Figure 3.1) acted as the control and theoretically represents that
probiotic’s optimal growth. The control was compared against MRS broth at 25ºC (temperature
difference), tea at recommended temperature (medium difference), and tea at 25ºC (fermentation
conditions) to identify any significant differences. Table 3.2 lists all model equations used for
comparison as well as suitability of equation fit. Table 3.3 illustrates the model comparisons of
each probiotic among the three different treatments and their respective p-values. In every case
except L. bulgaricus in MRS broth at 25ºC, decreasing the temperature resulted in significantly
reduced growth of the probiotic. Switching the medium from MRS broth to sweetened tea led to
a significant reduction in survival. However, comparing the models of tea at recommended
temperature and tea at 25ºC revealed there was better cell survival at 25ºC than at the
recommended temperature.
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Table 3.2. Model Equations for Lactobacillus species grown under ideal conditions and in
kombucha-relevant conditions
Probiotic

Medium1

Temperature
(°C)

Model Equation

R2

L. bulgaricus

MRS

37

49%

L. bulgaricus

MRS

25

𝑦 = −0.0003𝑥 4 + 0.0158𝑥 3
− 0.2876𝑥 2
+ 2.1626𝑥 + 3.6383
𝑦 = −0.0088𝑥 2 + 0.3307𝑥
+ 6.5963

L. bulgaricus

Tea

37

93%

L. bulgaricus

Tea

25

𝑦 = 0.0001𝑥 4 − 0.0054𝑥 3
+ 0.0917𝑥 2
− 0.6817𝑥 + 8.4194
𝑦 = 0.0017𝑥 2 + 0.0949𝑥
+ 7.3217

L. plantarum

MRS

37

𝑦 = 0.0005𝑥 3 − 0.0310𝑥 2
+ 0.5817𝑥 + 5.9533

97%

L. plantarum

MRS

25

𝑦 = −0.0071𝑥 2 + 0.3320𝑥
+ 5.5583

93%

L. plantarum

Tea

37

𝑦 = 0.0077𝑥 2 − 0.2821𝑥
+ 7.5797

88%

L. plantarum

Tea

25

𝑦 = 0.0023𝑥 2 + 0.1287𝑥
+ 7.1947

79%

L. brevis

MRS

30

68%

L. brevis

MRS

25

𝑦 = 0.0001𝑥 5 − 0.0069𝑥 4
+ 0.1873𝑥 3
− 2.3181𝑥 2
+ 12.9102𝑥
+ 18.4867
3
𝑦 = 0.0007𝑥 − 0.0374𝑥 2
+ 0.6603𝑥 + 5.7267

L. brevis

Tea

30

62%

L. brevis

Tea

25

𝑦 = 0.00003𝑥 5 − 0.0020𝑥 4
+ 0.0491𝑥 3
− 0.5706𝑥 2
+ 2.9986𝑥 + 1.0267
𝑦 = −0.0264𝑥 + 7.2356

L. fermentum

MRS

37

𝑦 = −0.0084𝑥 2 + 0.3358𝑥
+ 5.7133

84%

90

94%

44%

98%

37%

Table 3.2. Continued
L. fermentum

MRS

25

𝑦 = −0.0021𝑥 2 + 0.1145𝑥
+ 6.796

85%

L. fermentum

Tea

37

44%

L. fermentum

Tea

25

L. casei

MRS

37

𝑦 = −0.0004𝑥 4 + 0.0201𝑥 3
− 0.3703𝑥 2
+ 2.6344𝑥 + 0.1067
𝑦 = (−1.1583 ∗ 10−5 )𝑥 5
+ 0.0008𝑥 4
− 0.0192𝑥 3
+ 0.2245𝑥 2
− 1.1744𝑥 + 8.56
3
𝑦 = −0.0008𝑥 + 0.0296𝑥 2
− 0.2215𝑥 + 7.7767

L. casei

MRS

25

𝑦 = −0.0009𝑥 2 + 0.1120𝑥
+ 6.3447

87%

L. casei

Tea

37

𝑦 = −0.0010𝑥 2 − 0.1479𝑥
+ 8.225

81%

L. casei

Tea

25

𝑦 = −0.0043𝑥 2 + 0.0453𝑥
+ 6.7817

48%

L. sakei

MRS

30

𝑦 = −0.0005𝑥 3 + 0.0191𝑥 2
− 0.1526𝑥 + 6.4189

12%

L. sakei

MRS

25

𝑦 = −0.0005𝑥 3 + 0.0215𝑥 2
− 0.2060𝑥 + 7.713

91%

L. sakei

Tea

30

𝑦 = 0.0086𝑥 2 − 0.3182𝑥 + 6.798

81%

L. sakei

Tea

25

𝑦 = 0.0015𝑥 3 − 0.0672𝑥 2
+ 0.6808𝑥 + 5.1567

96%

37%

92%

1

: Medium consisted of either MRS broth or sweetened tea

Figure 3.1 illustrates the growth treatments for each probiotic and denote these significant
differences along with the final pH values for each treatment. The bacterial curves demonstrate
that medium and temperature did have an effect on probiotic growth, but the effects are not
necessarily negative when combined. The combination of temperature and medium differences
lessens the expected negative effect. In tea medium at 25ºC, although population did not
increase, there was still a good amount of probiotic alive at the end of the 24 hours, notably L.
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bulgaricus, L. brevis, and L. fermentum which all had a final population of ˃6.0 log. The
remaining three LAB, L. plantarum, L. casei, and L. sakei, had final populations of 5.4 log, 5.4
log, and 4.0 log, respectively. At the end of the 24 hours, every probiotic had an equal or higher
population level in sweet tea at 25ºC than sweet tea at the recommended temperature (refer to
Figure 3.1).
These observations are reinforced by the pH values associated with each growth curve. A
lower pH indicates there is more acid in the sample, and thus, there are more cells present
because they produce the acid. The difference in pH of the MRS control (no probiotic present)
and the probiotics in MRS broth is much greater than the difference in pH of the tea control (no
probiotics present) and the probiotics in the tea. This is because the cells in the tea medium did
not grow whereas the cells in the MRS broth did grow.
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Figure 3.1. Bacterial Growth Curves (i) and pH values (ii) for A. L. plantarum, B. L.
bulgaricus, C. L. brevis, D. L. fermentum, E. L. casei, F. L. sakei
Figure represents survival of probiotic populations within each treatment (n= 6). All growth
curves within pane are significantly different unless marked with (*). Letters on pH panes
indicate significant differences (p<0.05) between pH values, including controls MRS broth and
sweet tea.
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Figure 3.1. Continued
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Table 3.3. Model Comparisons of Individual Probiotics
Each treatment of a probiotic compared to its control.
L. plantarum
Comparison

p-value1

MRS at 37ºC vs. MRS at 25ºC

6.069e-9

MRS at 37ºC vs. Tea at 37ºC

2.2e-16

MRS at 37ºC vs. Tea at 25ºC

2.2e-16

Tea at 37ºC vs. Tea at 25ºC

1.126e-5

L. bulgaricus
Comparison

p-value1

MRS at 37ºC vs. MRS at 25ºC

0.1076

MRS at 37ºC vs. Tea at 37ºC

2.2e-16

MRS at 37ºC vs. Tea at 25ºC

9.519e-15

Tea at 37ºC vs. Tea at 25ºC

0.005204

L. brevis
Comparison

p-value1

MRS at 30ºC vs. MRS at 25ºC

1.349e-10

MRS at 30ºC vs. Tea at 37ºC

5.349e-7

MRS at 30ºC vs. Tea at 25ºC

1.283e-4

Tea at 30ºC vs. Tea at 25ºC

1.627e-5

L. fermentum
Comparison

p-value1

MRS at 37ºC vs. MRS at 25ºC

4.559e-6

MRS at 37ºC vs. Tea at 37ºC

6.377e-14
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Table 3.3. Continued
MRS at 37ºC vs. Tea at 25ºC

2.2e-16

Tea at 37ºC vs. Tea at 25ºC

0.0001564

L. casei
Comparison

p-value1

MRS at 37ºC vs. MRS at 25ºC

3.479e-6

MRS at 37ºC vs. Tea at 37ºC

2.845e-16

MRS at 37ºC vs. Tea at 25ºC

2.446e-13

Tea at 37ºC vs. Tea at 25ºC

0.003595

L. sakei
Comparison

p-value1

MRS at 30ºC vs. MRS at 25ºC

0.02378

MRS at 30ºC vs. Tea at 37ºC

4.228e-7

MRS at 30ºC vs. Tea at 25ºC

3.541e-5

Tea at 30ºC vs. Tea at 25ºC

3.841e-10

1

Significance identified when obtain a p-value of <0.05

As seen in Figure 3.1, the probiotic populations do not increase in the sweetened tea, and
the pH did not decrease enough from the tea control to the end of the growth period to indicate
tea is able to be acidified by the acid produced from probiotics alone. Therefore, it can be
concluded that this amount of cultures cannot be used alone to acidify the tea. Previous
kombucha or acetic acid needs to be added to acidify the tea pre-fermentation. The question
becomes if we can get the probiotics to survive by adding a higher concentration.
Having the probiotics grow in sweet tea at 25ºC mimics the conditions at which
kombucha fermentation would take place. Results previously discussed allow us to have a full
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picture of the response of each individual probiotic to the conditions that would be necessary to
include it in a probiotic kombucha product. It is also valuable, however, to understand whether
certain probiotics show more promise for this purpose than others. To this end, each probiotic
was compared to every other strain in tea at 25ºC to identify any significant differences. Table
3.4 illustrates the comparisons of each probiotic to one another and their respective p-values. The
plethora of statistical differences (with the exception of L. bulgaricus compared to L. casei)
reveals that each probiotic is going to act differently during the fermentation process. L. brevis
(0.50 logCFU/ml reduction) and L. fermentum (0.53 logCFU/ml increase) survived significantly
better than the remaining probiotics; L. casei (1.48 logCFU/ml reduction) and L. sakei (2.98
logCFU/ml reduction) performed significantly worse than the other four probiotics. If a certain
amount of L. brevis and L. fermentum are inoculated into the kombucha beverage, the two
probiotics are most likely to survive and retain most, if not all, of their populations based on their
models. Therefore, it can be predicted from these comparisons that L. brevis and L. fermentum
are best suited for use in a traditionally fermented kombucha product, based on their superior
survival during fermentation, while L. casei and L. sakei are the least likely to be used in a
fermented beverage.
L. brevis and L. fermentum’s acid tolerances further confirm their abilities to survive and
grow in kombucha as well as a human’s stomach and GI tract. Stomach acidity can range from a
pH of 1.5-3.0, and consumption of food usually raises it to 3.0 or higher (Kandola et al., 2016;
Zeng, Pan, & Zhou, 2011). L. brevis starts to decrease in population at a pH below 3.0, but its
cell death rate was found to decrease at approximately <1.0 log CFU/mL per every 0.5 unit
decrease in pH, meaning its survival rate is still fairly robust (Wu et al., 2018). L. fermentum has
been found to be resistant to a pH of 2.0, and viable counts have been shown to stay constant at a
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pH of 3.0 (Zeng, Pan, & Zhou, 2011; Melia et al., 2018). Comparatively, L. plantarum, L. casei,
L. sakei, and L. bulgaricus prefer a slightly higher pH, usually >3.0, or else viability and
populations start to become severely reduced by several log CFU/mL (Zhang, Wu, Du, & Chen,
2012; Boke, Aslim, & Alp, 2010; Guo et al., 2017; Hong, Kim, & Pyun, 1999; Shah & Jelen,
1990). This strain of L. bulgaricus especially is known to be low-acid tolerant and thrives best in
a less acidic pH (>4.0) (Shah & Jelen, 1990). In order to guarantee probiotic presence in the
kombucha beverage and the GI tract, we should select a probiotic with a better acid tolerance.

Table 3.4. Model Comparisons Between Probiotics in Tea at 25ºC
Comparison
(Tea at 25ºC)
L. bulgaricus vs. L. casei

p-value1
0.370

Which species
performed better?
N/A

L. plantarum vs. L. casei

0.024

L. casei

L. brevis vs. L. casei

0.006

L. brevis

L. brevis vs. L. fermentum

3.165e-4

L. brevis

L. fermentum vs. L. casei

0.003

L. fermentum

L. bulgaricus vs. L. fermentum

0.002

L. fermentum

L. bulgaricus vs. L. plantarum

0.002

L. bulgaricus

L. bulgaricus vs. L. brevis

0.002

L. brevis

L. casei vs. L. sakei

2.796e-5

L. casei

L. plantarum vs. L. sakei

1.752e-6

L. plantarum

L. bulgaricus vs. L. sakei

3.123e-8

L. bulgaricus

L. plantarum vs. L. fermentum

4.833e-10

L. fermentum
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Table 3.4. Continued
L. plantarum vs. L. brevis

9.439e-11

L. brevis

L. brevis vs. L. sakei

1.272e-12

L. brevis

L. fermentum vs. L. sakei

6.95e-13

L. fermentum

1

Significance identified when obtain a p-value of <0.05

3.4.2 Probiotic Population Curves and Health Claims
Literature indicates on average that the pH of finished kombucha is around 2.5, but there
is no pH defined for “finished” kombucha (Greenwalt, Steinkraus, & Ledford, 2000; Greenwalt,
Ledford, & Steinkraus, 1998; Nummer, 2013). The pH of kombucha may also fluctuate during
storage (shelf-life) unpredictably, and pH is often not tested after leaving the production facility
(Yıkmış & Tuğgüm, 2019; La Torre, 2021). The Centers for Disease Control and Prevention
(CDC) recommends kombucha under a pH of 2.5 or above a pH of 4.0 not be consumed due to
safety concerns, but it seems anywhere in between this range may be acceptable. The pH chosen
for this study to determine when fermentation was “complete” was 3.0. The kombucha jars
completed fermentation from a range of 7 to 11 days with an average of 8.3 days, as shown in
Table 3.5.

Table 3.5. Longevity of Fermentation for Each Replicate
Probiotic

Days of Fermentation

L. plantarum

8.2 ± 0.4

L. bulgaricus

9.0 ± 0.5

L. brevis

8.8 ± 0.5
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Table 3.5. Continued
L. fermentum

8.0 ± 0.3

L. casei

8.0 ± 0.4

L. sakei

7.8 ± 0.4

Avg.

8.3 ± 0.2

Figure 3.2 illustrates the probiotic populations throughout sweet tea fermentation into
kombucha. For all six probiotics, there was an initial drop in population of ~2 log CFU/mL on
average when the probiotic culture is added into the acidified tea (from Culture to Day 0). The
populations plateau for several days for four out of the six probiotics (L. plantarum, L.
bulgaricus, L. brevis, L. fermentum) until decreasing markedly in the later stages of fermentation
(day 6/7). At the end of the kombucha jars’ fermentation periods, L. brevis and L. bulgaricus
maintained the highest populations whereas L. sakei, L. casei, L. fermentum, and L. plantarum
were all undetectable (0 CFU/mL). L. sakei was the quickest to reach undetectable levels (4
days) followed by L. casei (6 days). Looking at previous data (Figure 3.1), this was expected
because L. sakei and L. casei had the largest decreases in population as well as the smallest
populations at the end of the 24-hour sample period among the six probiotics. L. fermentum and
L. plantarum, however, did not reach under the detection limit until ≥9 days, which roughly
corresponded with the end of active fermentation. L. brevis consistently had highest population
counts among all the probiotics throughout fermentation, moreover, it also retained viability
during storage, despite a steep decrease in population level during that time. For this reason, L.
brevis and L. bulgaricus have demonstrated the most promise for kombucha fermentation and
creating a probiotic beverage.
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Figure 3.2. Averaged Lactobacillus sp. Population during Kombucha Fermentation and
Storage
n=6. Error bars represent ± standard error for each data point.

Figure 3.3. Mean Lactobacillus sp. pH values during Kombucha Fermentation
pH was taken every 24 hours until a pH of ≤3.≥ was reached (n=a million).
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Based on the growth curves and pH values of the probiotics during kombucha
fermentation, we could say if we want to have a probiotic kombucha, then the kombucha should
not be fermented below a pH of ~3.2. At that point, as mentioned previously, the probiotics seem
to hit an acidic threshold where they tend to die off if that threshold is surpassed (Zhang, Wu,
Du, & Chen, 2012; G-Alegrıá et al., 2004; Boke, Aslim, & Alp, 2010). Based on Figure 3.2, the
time it takes to reach that threshold was generally around Day 6 or Day 7. Assuming the storage
period will decrease the pH of the kombucha (no SCOBY present) by 0.3-0.5 on average after
six weeks (Dankwa, 2021), it can be recommended the fermentation should be stopped at 3.5 to
obtain a final pH of 3.2 if the goal is to maintain viability of naturally present or inoculated LAB.
In order to have an effective probiotic drink, a certain viable concentration of specified
probiotic per serving of kombucha is necessary. According to most nutrition labels, an average
serving size of kombucha is 16 fluid oz. A manufacturer would need to ensure enough probiotic
is being consumed per serving in order for a health effect to occur and a health claim to be made.
However, it is not possible to state a minimum dose for all probiotics in all food vehicles. Each
species and strain require different dosages to be effective for a specific health effect
(McFarland, 2015; Sanders, n.d.). These efficacy dosages can range from 50 million CFU/day to
1 trillion CFU/day depending on the product (Sanders, n.d.). In food products, microorganisms
are usually found in lower ranges from 106-107 CFU/mL or CFU/g because you consume more
of it compared to a supplement capsule (Bertazzoni et al., 2013). In a 16 fluid oz serving of
kombucha, this level would require approximately 4.73x108-9 CFU/mL of live probiotic.
Table 3.6 describes some recommended dosages for the six Lactobacillus sp. studied in
this research experiment in order to make specific health claims. Nonetheless, making a health
claim on a product is extremely complicated, especially when it involves probiotics. Health
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claims describe the relationship between a food or food component and reducing the risk of a
disease or health-related condition, and these health claims must have supporting evidence in
human trials (Donovan et al., 2012). On top of that, as of right now there is no legal definition or
standard identity for the term ‘probiotic’ in the United States or Europe (Donovan et al., 2012;
Sanders, n.d.).

Table 3.6. Minimum Dosages of L. plantarum, L. bulgaricus, L. brevis, L. fermentum, L.
casei, and L. sakei Needed to Make Specific Health Claims
Probiotic
L. plantarum

Recommended Dosage
107 minimum dose

Alleviation of symptoms of
intestinal gas in IBS patients

1.2x109 CFU/day

Lowers cholesterol

1010 CFU per day

10 billion CFU/day

L. bulgaricus

Health Effect

Reduction of the incidence of
gastrointestinal symptoms
associated with antibiotic
treatment
Decrease of antibiotic-associated
diarrhea in children

Reference(s)
Jew et al., 2008;
Behera, Ray, &
Zdolec, 2018
Fuentes et al.,
2013
Seddik et al.,
2017

Chakravorty et
al., 2019

5x107 CFU/day

Decrease in IBS symptoms

Bertazzoni et
al., 2013

10x109 CFU/day

Increased prevention of CDI in
those currently treated with
antibiotics [in hospital setting]
Gut homeostasis

KujawaSzewieczek et
al., 2015
Savard et al.,
2011

9x107 CFU/day

Increased innate immune system
stimulation

Moro-García et
al., 2013

≥108 CFU/g

Increased lactose digestion in those
with lactose maldigestion

EFSA Panel on
Dietetic
Products,
Nutrition and

107 CFU/100g
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Table 3.6. Continued
Allergies
(NDA), 2010
L. brevis

L. fermentum

L. casei

L. sakei

4x109 CFU/day

Increased oral health in school
children

Campus et al.,
2014

1.8x1011 CFU/day

Decreased H. pylori colonization

Linsalata et al.,
2004

2x1011 CFU/day

Reduction of traveler’s diarrhea
when taken 3 weeks before
traveling

McFarland,
2007

3x109 CFU/mL

Exhibition of anti-atherogenic
effects

Kullisaar et al.,
2003

1.6x109 CFU/day

Exhibition of antioxidative effects

Songisepp et al.,
2005

108-109 dose

Improvement of bowel movements
and support of a balanced gut
microbiota

Jew et al., 2008

10 billion CFU/day

Decrease of antibiotic-associated
diarrhea

Guo et al., 2019

6.5x109 CFU/day

Reduction of chronic constipation

3x1010 CFU/day

Prevention of the reoccurrence of
various cancers

Chmielewska &
Szajewska,
2010; Koebnick
et al., 2003
Shida &
Nomoto, 2013

4x1010 CFU/day

Enhancement of natural killer (NK)
cell activity

Shida &
Nomoto, 2013

108 CFU/day minimum

Decrease in rheumatoid arthritis
symptoms

VaghefMehrabany et
al., 2014

1x1010 CFU/day

Help with body fat mass reduction
in those with obesity

Lim et al., 2020
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3.4.3 GC-MS Analysis of Biogenic Amines
The MRS broth and unfermented sweetened tea samples inoculated with the six LAB
used to identify the bacterial growth curves were analyzed by GC-MS to identify the presence of
amines. By analyzing the MRS broth inoculated samples, it possible to distinguish the amino
acids and biogenic amines these probiotics can produce in an ideal medium. Various amino acids
and biogenic amines were detected, but they were in too small of amounts to make a significant
impact. By analyzing the unfermented sweetened tea samples, it was possible to determine if the
small amounts of various amino acids and biogenic amines could be produced in a less ideal
medium. Analysis determined there were no biogenic amines present in these samples. However,
as would be expected in tea, the samples did contain caffeine, theanine, and traces of aspartic
acid.
Although the unfermented inoculated tea samples did not contain any biogenic amines,
this may not be the case after completing fermentation in conjunction with a SCOBY. The
species within the SCOBY produce metabolites during fermentation that are found in kombucha
but are not found in unfermented tea, hence the need to analyze the LAB inoculated kombucha
samples. Several samples were screened, but all samples were negative for GABA and other
biogenic amines at the detection limit of 1 μmol. This is because there were little to no free
amino acids to decarboxylate into biogenic amines. For example, if there is no glutamic acid
present in a sample, there will not be any GABA present in that sample either. Caffeine was
detected in all samples, and lysine was identified in three out of the nine samples. Because there
were no detectable biogenic amines, including GABA, it can be determined that there is not a
large enough presence of biogenic amines to warrant a health benefit upon consuming a serving
of kombucha.
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3.5 Conclusions
A change in medium (tea), temperature, and the combination of medium and temperature
all had an effect on the growth rate of the probiotics tested. Together, the change in medium and
temperature ameliorated those expected negative effects and resulted in better growth rates than
the medium change alone. The decrease in pH for every probiotic from the tea control to the tea
treatment at 25ºC was not great enough to indicate that the lactic acid bacteria tested could
acidify the sweetened tea pre-fermentation, replacing the need to use previous kombucha or
acetic acid. The kombucha fermentation showed an initial 2 log CFU/mL drop in probiotic
population when the cultures were added to the sweetened acidified tea. They then saw a plateau
in population for a few days until they began to significantly decrease around day 6. L.
fermentum and L. brevis were the only to two probiotics to survive with populations above the
detection limit at the end of fermentation. GABA and other biogenic amines were not detected in
the inoculated kombucha samples at a detection limit of 1 μmol. Overall, looking at the survival
rates it seems Lactobacillus sp. are not well suited to act as probiotics in a kombucha, but of
those tested, L. brevis and L. fermentum would be the best options of those tested in this work.
However, other probiotics that seem more promising in kombucha, such as Bacillus coagulans,
should be tested and further researched.
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